Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter

1.

Adolfsson P, Riddell MC, Taplin CE et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes. Pediatr Diabetes 19(Suppl. 27):205–226. https://doi.org/10.1111/pedi.12755CrossRefPubMed

2.

Agency for Health Care Policy and Research (AHCPR) (1992) Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline. Public Health Service, U.S. Department of Health and Human Services, Rockville

3.

Ahern JA, Ramchandani N, Cooper J, Himmel A, Silver D, Tamborlane WV (2000) Using a primary nurse manager to implement DCCT recommendations in a large pediatric program. Diabetes Educ 26:990–994 (EK III)PubMedCrossRef

4.

Al Hanshi S, Shann F (2011) Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med 12:137–140 (EK III)PubMedCrossRef

5.

Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M (2004) Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 27:1798–1811 (EK IV)PubMedCrossRef

6.

Ambrosino JM, Fennie K, Whittemore R, Jaser S, Dowd MF, Grey M (2008) Short-term effects of coping skills training in school-age children with type 1 diabetes. Pediatr Diabetes 9:74–82 (EK Ib)PubMedPubMedCentralCrossRef

7.

American Diabetes Association (2003) Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 26:2194–2197 (EK IV)CrossRef

8.

American Diabetes Association (2009) Standards of medical care in diabetes—2009. Diabetes Care 32(Suppl 1):S13–S61 (EK IV)PubMedCentralCrossRef

9.

American Diabetes Association (2015) Standards of Medical Care in Diabetes—2015. Section 11: Children and Adolescents. Diabetes Care 38:S70–S76 (EK IV)CrossRef

10.

Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB (2002) A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 25:1117–1122 (EK III)PubMedCrossRef

11.

Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER (2006) Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care 29:2660–2663 (EK III)PubMedCrossRef

12.

Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L (1997) Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. J Pediatr 130:257–265 (EK III)PubMedCrossRef

13.

Anderson BJ, Brackett J, Ho J, Laffel LM (1999) An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care 22:713–721 (EK IIb)PubMedCrossRef

14.

Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC (1995) Patient empowerment. Results of a randomized controlled trial. Diabetes Care 18:943–949 (EK Ib)PubMedCrossRef

15.

Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 289:2083–2093 (EK Ib)PubMed

16.

Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA): Therapie der Adipositas im Kindes- und Jugendalter. Evidenzbasierte Leitlinie der Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA) und der beteiligten medizinisch-wissenschaftlichen Fachgesellschaften, Berufsverbände und weiterer Organisationen, AGA, Ulm (2008) EK IV

17.

Arbeitsgemeinschaft für Pädiatrische Diabetologie (1998) Untersuchungen auf diabetische Folgeerkrankungen an Augen, Nieren und Nerven bei pädiatrischen Diabetespatienten. Diabet Inform 20:124–127

18.

Arbeitsgemeinschaft für Pädiatrische Diabetologie (1999) Stellungnahme zur Notwendigkeit eines Kinderpsychologen in der Langzeitbetreuung von Kindern und Jugendlichen mit Diabetes mellitus, 20. Aufl. AGPD,

19.

Arbeitsgemeinschaft für Pädiatrische Diabetologie (AGPD) (2009) Kinder mit Diabetes im Kindergarten. Informationen für Erzieherinnen und Erzieher in Kindergärten (http://www.diabetes-kinder.de, EK IV)

20.

Arbeitsgemeinschaft für Pädiatrische Diabetologie (AGPD) (2010) Kinder mit Diabetes in der Schule. Informationen für Lehrerinnen und Lehrer (http://www.diabetes-kinder.de, EK IV)

21.

Arbeitsgemeinschaft Pädiatrische Diabetologie (AGPD) (1999) Kosten der ambulanten Langzeitbetreuung (EK IV)

22.

Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO (2000) The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr 83(Suppl 1):S25–S32 (EK Ia)PubMedCrossRef

23.

Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) (2005a) Clinical practice guidelines: Type 1 diabetes in children and adolescents (EK IV)

24.

Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) (2005) Clinical practice guidelines: Type 1 diabetes in children and adolescents (EK Ib)

25.

Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) (2005) Clinical practice guidelines: Type 1 diabetes in children and adolescents. Department of Health, (EK IIb–III)

26.

Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) (2005) Clinical practice guidelines: Type 1 diabetes in children and adolescents (EK III)

27.

Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) (2005) Clinical practice guidelines:Type1diabetes in children and adolescents, EK III/IV

28.

Babcock DS (2006) Thyroid disease in the pediatric patient: emphasizing imaging with sonography. Pediatr Radiol 36:299–308 (quiz, EK IV)PubMedCrossRef

29.

Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R, Bryan J, guilar-Bryan L, Vaxillaire M, Froguel P (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456–466 (EK III)PubMedCrossRef

30.

Bachran R, Beyer P, Klinkert C, Heidtmann B, Rosenbauer J, Holl RW (2012) Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes 13:1–5 (EK III)PubMedCrossRef

31.

Badenhoop K, Kordonouri O, Machicao F (2008) Empfehlungen zur molekulargenetischen Diagnostik bei Verdacht auf MODY. DDG, (EK IV)

32.

Baechle C, Castillo K, Strassburger K, Stahl-Pehe A, Meissner T, Holl RW, Giani G, Rosenbauer J (2014) Is disordered eating behavior more prevalent in adolescents with early-onset type 1 diabetes than in their representative peers? Int J Eat Disord 47:342–352 (EK IIb)PubMedCrossRef

33.

Ballmann M, Hubert D, Assael BM, Kronfeld K, Honer M, Holl RW (2014) Open randomised prospective comparative multicentre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus. BMC Pediatr 14:70 (EK Ib)PubMedPubMedCentralCrossRef

34.

Bangstad HJ, Danne T, Deeb LC, Jarosz-Chobot P, Urakami T, Hanas R (2007) Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 8:88–102 (EK Ib)PubMedCrossRef

35.

Bangstad HJ, Danne T, Deeb LC, Jarosz-Chobot P, Urakami T, Hanas R (2007) Insulin treatment. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 8:88–102 (EK IV)PubMedCrossRef

36.

Banks CJ, Furyk JS (2008) Review article: hypertonic saline use in the emergency department. Emerg Med Australas 20:294–305 (EK III)PubMed

37.

Barlow JH, Ellard DR (2004) Psycho-educational interventions for children with chronic disease, parents and siblings: an overview of the research evidence base. Child Care Health Dev 30:637–645 (EK Ib)PubMedCrossRef

38.

Barnard K, Thomas S, Royle P, Noyes K, Waugh N (2010) Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr 10:50 (EK Ia)PubMedPubMedCentralCrossRef

39.

Barnea-Goraly N, Raman M, Mazaika P, Marzelli M, Hershey T, Weinzimer SA, Aye T, Buckingham B, Mauras N, White NH, Fox LA, Tansey M, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL (2014) Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care 37:332–340 (EK III)PubMedPubMedCentralCrossRef

40.

Battaglia D, Lin YW, Brogna C, Crino A, Grasso V, Mozzi AF, Russo L, Spera S, Colombo C, Ricci S, Nichols CG, Mercuri E, Barbetti F (2012) Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225 T, del226–232 mutation. Pediatr Diabetes 13:656–660PubMedPubMedCentralCrossRef

41.

Battelino T, Conget I, Olsen B, Schutz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J (2012) The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55:3155–3162 (EK Ib)PubMedPubMedCentralCrossRef

42.

Battelino T, Danne T, Bergenstal RM et al (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care https://doi.org/10.2337/dci19-0028CrossRef

43.

Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolindern J (2011) Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 34:795–800 (EK Ib)PubMedPubMedCentralCrossRef

44.

Becker M, Galler A, Raile K (2014) Meglitinide analogues in adolescent patients with HNF1A-MODY (MODY 3). Pediatrics 133:e775–e779PubMedCrossRef

45.

Bell KJ, Barclay AW, Petocz P, Colagiuri S, Brand-Miller JC (2014) Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2:133–140PubMedCrossRef

46.

Berg CA, Schindler I, Maharajh S (2008) Adolescents’ and mothers’ perceptions of the cognitive and relational functions of collaboration and adjustment in dealing with type 1 diabetes. J Fam Psychol 22:865–874 (EK III)PubMedCrossRef

47.

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224–232 (EK Ib)PubMedCrossRef

48.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363:311–320 (EK Ib)PubMedCrossRef

49.

Biester T, Blaesig S, Remus K, Aschemeier B, Kordonouri O, Granhall C, Sondergaard F, Kristensen NR, Haahr H, Danne T (2014) Insulin degludec’s ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes. Pediatr Diabetes 15:27–33PubMedCrossRef

50.

Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76–131 (EK Ib–IV)PubMedCrossRef

51.

Bitsko MJ, Bean MK, Bart S, Foster RH, Thacker L, Francis GL (2013) Psychological treatment improves hemoglobin A1c outcomes in adolescents with type 1 diabetes mellitus. J Clin Psychol Med Settings 20:333–342 (EK III)PubMedCrossRef

52.

Blackman SM, Raghinaru D, Adi S, Simmons JH, Ebner-Lyon L, Chase HP, Tamborlane WV, Schatz DA, Block JM, Litton JC, Raman V, Foster NC, Kollman CR, DuBose SN, Miller KM, Beck RW, Dimeglio LA (2014) Insulin pump use in young children in the T1 D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatr Diabetes 15:564–572 (EK IIb)PubMedCrossRef

53.

Blank W, Braun B (2008) Sonografie der Schilddrüse – Teil 2: Schilddrüsenentzündungen, Schilddrüsenfunktionsstörungen und Interventionen. Ultraschall in Med 29:128–149, EK IV

54.

Blankfield AJ, Holahan B (1996) Family support, coping strategies and depressive symptoms among mothers of children with diabetes. J Fam Psychol 10:173–179 (EK III)CrossRef

55.

Bläsig S, Remus K, Danne T, Lange K (2011) “Fit for school”: evaluation of a training course for 5–6 year old children with type 1 diabetes. Pediatr Diabetes 12:72 (EK III)

56.

Bloomgarden ZT, Karmally W, Metzger MJ, Brothers M, Nechemias C, Bookman J, Faierman D, Ginsberg-Fellner F, Rayfield E, Brown WV (1987) Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care 10:263–272 (EK Ib)PubMedCrossRef

57.

Bonfanti R, Colombo C, Nocerino V, Massa O, Lampasona V, Iafusco D, Viscardi M, Chiumello G, Meschi F, Barbetti F (2009) Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes Care 32:123–125PubMedPubMedCentralCrossRef

58.

Bonfig W, Kapellen T, Dost A, Fritsch M, Rohrer T, Wolf J, Holl RW (2012) Growth in children and adolescents with type 1 diabetes. J Pediatr 160:900–903PubMedCrossRef

59.

Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I, Vambergue A, Vatin V, Delplanque J, Le GD, De GF, Lecoeur C, Sand O, Vaxillaire M, Froguel P (2012a) Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS ONE 7(e37):423

60.

Bonnefond A, Sand O, Guerin B, Durand E, De GF, Huyvaert M, Rachdi L, Kerr-Conte J, Pattou F, Vaxillaire M, Polak M, Scharfmann R, Czernichow P, Froguel P (2012b) GATA6 inactivating mutations are associated with heart defects and, inconsistently, with pancreatic agenesis and diabetes. Diabetologia 55:2845–2847PubMedCrossRef

61.

Bornet F, Haardt MJ, Costagliola D, Blayo A, Slama G (1985) Sucrose or honey at breakfast have no additional acute hyperglycaemic effect over an isoglucidic amount of bread in type 2 diabetic patients. Diabetologia 28:213–217 (EK Ib)PubMedCrossRef

62.

Brackenridge A, Wallbank H, Lawrenson RA, Russell-Jones D (2006) Emergency management of diabetes and hypoglycaemia. Emerg Med J 23:183–185 (EK III)PubMedPubMedCentralCrossRef

63.

Brand-Miller J, Hayne S, Petocz P, Colagiuri S (2003) Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 26:2261–2267 (EK Ia)PubMedCrossRef

64.

Brink S, Laffel L, Likitmaskul S, Liu L, Maguire AM, Olsen B, Silink M, Hanas R (2007) Sick day management in children and adolescents with diabetes. Pediatr Diabetes 8:401–407 (EK IV)PubMedCrossRef

65.

Brink S, Laffel L, Likitmaskul S, Liu L, Maguire AM, Olsen B, Silink M, Hanas R (2007) Sick day management in children and adolescents with diabetes. Pediatr Diabetes 8:401–407PubMedCrossRef

66.

Brown M, Ahmed ML, Clayton KL, Dunger DB (1994) Growth during childhood and final height in type 1 diabetes. Diabet Med 11:182–187 (EK III)PubMedCrossRef

67.

Bryden KS, Neil A, Mayou RA, Peveler RC, Fairburn CG, Dunger DB (1999) Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 22:1956–1960 (EK III)PubMedCrossRef

68.

Buckingham BA, Cameron F, Calhoun P, Maahs DM, Wilson DM, Chase HP, Bequette BW, Lum J, Sibayan J, Beck RW, Kollman C (2013) Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 15:622–627 (EK Ib)PubMedPubMedCentralCrossRef

69.

Bundesarbeitsgemeinschaft für Rehabilitation (BAR). (2008) Gemeinsames Rahmenkonzept der Gesetzlichen Krankenkassen und der Gesetzlichen Rentenversicherung für die Durchführung stationärer medizinischer Leistungen der Vorsorge und Rehabilitation für Kinder und Jugendliche. http://www.bar-frankfurt.de/fileadmin/dateiliste/publikationen/arbeitsmaterialien/downloads/Gemeinsames_Rahmenkonzept.pdf

70.

Bundesärztekammer (BÄK), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV) (2012) Nationale VersorgungsLeitlinie Diabetes. Strukturierte Schulungsprogramme – Langfassung, 1. Aufl., S 143 https://doi.org/10.6101/AZQ/000 (Version 3, EK IV)CrossRef

71.

Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2010) Nationales Programm für VersorgungsLeitlinien, 4. Aufl. Methoden-Report. https://doi.org/10.6101/AZQ/000061CrossRef

72.

Cadario F, Prodam F, Bellone S, Trada M, Binotti M, Trada M, Allochis G, Baldelli R, Esposito S, Bona G, Aimaretti G (2009) Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach. Clin Endocrinol (oxf) 71:346–350 (EK III)CrossRef

73.

Cameron FJ, Amin R, de BC, Codner E, Acerini CL ISPAD Clinical Practice Consensus Guidelines 2014. Diabetes in adolescence. Pediatr Diabetes 2014(15):245–256 (EK III)

74.

Cameron FJ, de Beaufort BC, Aanstoot HJ, Hoey H, Lange K, Castano L, Mortensen HB (2013) Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach. Pediatr Diabetes 14:473–480 (EK III)PubMedCrossRef

75.

Cameron FJ, Scratch SE, Nadebaum C, Northam EA, Koves I, Jennings J, Finney K, Neil JJ, Wellard RM, Mackay M, Inder TE (2014) Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. Diabetes Care 37:1554–1562 (EK IIb)PubMedPubMedCentralCrossRef

76.

Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njolstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE (2008) Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes? Diabet Med 25:463–468 (EK III)PubMedCrossRef

77.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Canadian Diabetes Association (2013) Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013(37):1–S212 (EK IV)

78.

Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Lindberg BA, Sjoberg KG, Ivarsson SA (1999) Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 103:1248–1252, EK III

79.

Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ (1991) Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (lond) 81:739–742 (EK Ib)CrossRef

80.

Chan CL, Vigers T, Pyle L, Zeitler PS, Sagel SD, Nadeau KJ (2018) Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline. J Cyst Fibros 17(6):783–790PubMedPubMedCentralCrossRef

81.

Chan NN, Brain HP, Feher MD (1999) Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet Med 16:273–281 (EK IIa)PubMedCrossRef

82.

Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ (2000) Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342:1392–1398 (EK Ib)PubMedCrossRef

83.

Channon SJ, Huws-Thomas MV, Rollnick S, Hood K, Cannings-John RL, Rogers C, Gregory JW (2007) A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care 30:1390–1395 (EK Ib)PubMedCrossRef

84.

Chetty VT, Almulla A, Odueyungbo A, Thabane L (2008) The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabetes Res Clin Pract 81:79–87 (EK Ia)PubMedCrossRef

85.

Cheung N, Rogers SL, Donaghue KC, Jenkins AJ, Tikellis G, Wong TY (2008) Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care 31:1842–1846 (EK IIb)PubMedPubMedCentralCrossRef

86.

Chiang JL, Kirkman MS, Laffel LM, Peters AL (2014) Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 37:2034–2054PubMedPubMedCentralCrossRef

87.

Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O (1997) Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 20:881–887 (EK Ib)PubMedCrossRef

88.

Churchill JN, Ruppe RL, Smaldone A (2009) Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review. J Pediatr Health Care 23:173–179 (EK 1a)PubMedCrossRef

89.

Clar C, Waugh N, Thomas S (2007) Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus. Cochrane Database Syst Rev CD004 099: (EK IIa–III)

90.

Clarke W, Deeb LC, Jameson P, Kaufman F, Klingensmith G, Schatz D, Silverstein JH, Siminerio LM (2013) Diabetes care in the school and day care setting. Diabetes Care 36:S75–S79 (EK IV)PubMedCrossRef

91.

Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ (2008a) Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 9:165–174 (EK IV)PubMedCrossRef

92.

Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ (2008) Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 9:165–174 (EK III)PubMedCrossRef

93.

Cochran JB, Walters S, Losek JD (2006) Pediatric hyperglycemic hyperosmolar syndrome: diagnostic difficulties and high mortality rate. Am J Emerg Med 24:297–301 (EK III)PubMedCrossRef

94.

Colombo C, Porzio O, Liu M, Massa O, Vasta M, Salardi S, Beccaria L, Monciotti C, Toni S, Pedersen O, Hansen T, Federici L, Pesavento R, Cadario F, Federici G, Ghirri P, Arvan P, Iafusco D, Barbetti F (2008) Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 118:2148–2156 (EK III)PubMedPubMedCentral

95.

Colquitt J, Royle P, Waugh N (2003) Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet Med 20:863–866 (EK Ia)PubMedCrossRef

96.

Colton P, Olmsted M, Daneman D, Rydall A, Rodin G (2004) Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diabetes Care 27:1654–1659 (EK III)PubMedCrossRef

97.

Colton PA, Olmsted MP, Daneman D, Rodin GM (2013) Depression, disturbed eating behavior, and metabolic control in teenage girls with type 1 diabetes. Pediatr Diabetes 14:372–376 (EK III)PubMedCrossRef

98.

Copeland PM, Anderson B (1995) Diabetes mellitus and eating disorders. Harv Rev Psychiatry 3:36–40 (EK IV)PubMedCrossRef

99.

Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R (2000) Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Technol Assess 4:i–93 (EK Ia)PubMedCrossRef

100.

Couch R, Jetha M, Dryden DM (2008) Diabetes education for children with type 1 diabetes mellitus and their families. Agency for Healthcare Research and Quality (AHRQ), Rockville (EK Ia)

101.

Couper JJ, Haller MJ, Greenbaum CJ et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes 19(Suppl.27):20–27PubMedCrossRef

102.

Court JM, Cameron FJ, Berg-Kelly K, Swift PG (2008) Diabetes in adolescence. Pediatr Diabetes 9:255–262 (EK IV)PubMedCrossRef

103.

Craig ME, Twigg SM, Donaghue KC, Cheung NW, Cameron FJ, Conn J, Jenkins AJ, Silink M (2011) Australian Type Diabetes Guidelines Expert Advisory Group: National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Australian Government Department of Health and Ageing, Canberra (EK IV)

104.

Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA (1994) Restoration of hypoglycaemia awareness in patients with longduration insulin-dependent diabetes. Lancet 344:283–287 (EK III)PubMedCrossRef

105.

d’Emden H, Holden L, McDermott B, Harris M, Gibbons K, Gledhill A, Cotterill A (2013) Disturbed eating behaviours and thoughts in Australian adolescents with type 1 diabetes. J Paediatr Child Health 49:E317–E323, EK III

106.

Dalla Pozza R, Bechtold S, Bonfig W, Putzker S, Kozlik-Feldmann R, Netz H, Schwarz HP (2007) Age of onset of type 1 diabetes in children and carotid intima medial thickness. J Clin Endocrinol Metab 92:2053–2057 (EK IIb)PubMedCrossRef

107.

Danne T (2014) Deutscher Gesundheitsbericht. Diabetes 2014. http://www.diabetesde.org/fileadmin/users/Patientenseite/PDFs_und_TEXTE/Infomaterial/Gesundheitsbericht_2014_kl.pdf (EK IIb)

108.

Danne T, Aman J, Schober E, Deiss D, Jacobsen JL, Friberg HH, Jensen LH (2003) A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 26:2359–2364 (EK Ib)PubMedCrossRef

109.

Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, Urakami T, Battelino T, Hanas R (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 15:115–134 (EK IV)PubMedCrossRef

110.

Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pankowska E, Ludvigsson J, Schober E, Kaprio E, Saukkonen T, Nicolino M, Tubiana-Rufi N, Klinkert C, Haberland H, Vazeou A, Madacsy L, Zangen D, Cherubini V, Rabbone I, Toni S, de Beaufort C, Bakker-van WW, van den BN, Volkov I, Barrio R, Hanas R, Zumsteg U, Kuhlmann B, Aebi C, Schumacher U, Gschwend S, Hindmarsh P, Torres M, Shehadeh N, Phillip M (2008) Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 51:1594–1601PubMedCrossRef

111.

Danne T, Becker RH, Heise T, Bittner C, Frick AD, Rave K (2005) Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 28:2100–2105 (EK Ib)PubMedCrossRef

112.

Danne T, Datz N, Endahl L, Haahr H, Nestoris C, Westergaard L, Fjording MS, Kordonouri O (2008) Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial. Pediatr Diabetes 9:554–560 (EK Ib)PubMedCrossRef

113.

Danne T, Kordonouri O (2010) Use of technology to potentially preserve C‑Peptide in type 1 diabetes mellitus. Pediatr Endocrinol Rev 7(Suppl 3):396–400PubMed

114.

Danne T, Kordonouri O, Enders I, Weber B (1997) Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 20:281–285 (EK III)PubMedCrossRef

115.

Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F, Daneman D, Dorchy H, Garandeau P, Greene SA, Hoey H, Holl RW, Kaprio EA, Kocova M, Martul P, Matsuura N, Robertson KJ, Schoenle EJ, Sovik O, Swift PG, Tsou RM, Vanelli M, Aman J (2001) Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 24:1342–1347 (EK III)PubMedCrossRef

116.

Danne T, Nimri R, Battelino T et al (2017) International consensus on use of continous glucose monitoring. Diabetes Care 40:1631–1640PubMedPubMedCentralCrossRef

117.

Danne T, Phillip M, Buckingham BA et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 19(Suppl. 27):115–135. https://doi.org/10.1111/pedi.12718CrossRefPubMed

118.

Danne T, Philotheou A, Goldman D, Guo X, Ping L, Cali A, Johnston P (2013) A randomized trial comparing the rate of hypoglycemia–assessed using continuous glucose monitoring–in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study). Pediatr Diabetes 14(EK1b):593–601PubMedCrossRef

119.

Danne T, Rastam J, Odendahl R, Nake A, Schimmel U, Szczepanski R, Moeller J, Deiss D (2007) Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes. Pediatr Diabetes 8:278–285 (EK IIa)PubMedCrossRef

120.

Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR (2014) The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther 16:338–347 (EK IIb)PubMedCrossRef

121.

Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G (1994) Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 17:1390–1396 (EK III)PubMedCrossRef

122.

Danne T, Ziegler R, Kapellen T (2019) Diabetes bei Kindern und Jugendlichen. Dt. Gesundheitsbericht Diabetes. Kirchheim-Verlag, , S 124–135

123.

Davis CL, Delamater AM, Shaw KH, La Greca AM, Eidson MS, Perez-Rodriguez JE, Nemery R (2001) Parenting styles, regimen adherence, and glycemic control in 4‑ to 10-year-old children with diabetes. J Pediatr Psychol 26:123–129 (EK III)PubMedCrossRef

124.

de Beaufort CE, Lange K, Swift PG, Aman J, Cameron F, Castano L, Dorchy H, Fisher LK, Hoey H, Kaprio E, Kocova M, Neu A, Njolstad PR, Phillip M, Schoenle E, Robert JJ, Urukami T, Vanelli M, Danne T, Barrett T, Chiarelli F, Aanstoot HJ, Mortensen HB (2013) Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009. Pediatr Diabetes 14:422–428 (EK IIb)PubMedCrossRef

125.

de Man SA, Andre JL, Bachmann H, Grobbee DE, Ibsen KK, Laaser U, Lippert P, Hofman A (1991) Blood pressure in childhood: pooled findings of six European studies. J Hypertens 9:109–114 (EK IIb)PubMedCrossRef

126.

de Weerdt I, Visser AP, Kok GJ, de Weerdt O, van der Veen EA (1991) Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabet Med 8:338–345 (EK Ib)PubMedCrossRef

127.

de Wit M, Winterdijk P, Aanstoot HJ, Anderson B, Danne T, Deeb L, Lange K, Nielsen AO, Skovlund S, Peyrot M, Snoek F (2012) Assessing diabetes-related quality of life of youth with type 1 diabetes in routine clinical care: the MIND Youth Questionnaire (MY-Q). Pediatr Diabetes 13:638–646 (EK IV)PubMedCrossRef

128.

de Wit M, Delemarre-van de Waal HA, Bokma JA, Haasnoot K, Houdijk MC, Gemke RJ, Snoek FJ (2008) Monitoring and discussing health-related quality of life in adolescents with type 1 diabetes improve psychosocial well-being: a randomized controlled trial. Diabetes Care 31:1521–1526, EK Ib

129.

de Wit M, Pouwer F, Gemke RJ, Delemarre-van de Waal HA, Snoek FJ (2007) Validation of the WHO‑5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care 30:2003–2006 (EK III)PubMedCrossRef

130.

Decourcey DD, Steil GM, Wypij D, Agus MS (2013) Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality. Pediatr Crit Care Med 14:694–700 (EK III)PubMedCrossRef

131.

Deeb LC, Holcombe JH, Brunelle R, Zalani S, Brink S, Jenner M, Kitson H, Perlman K, Spencer M (2001) Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. Pediatrics 108:1175–1179 (EK Ib)PubMedCrossRef

132.

Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M (2006) Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 29:2730–2732 (EK Ib)PubMedCrossRef

133.

Delamater AM, Bubb J, Davis SG, Smith JA, Schmidt L, White NH, Santiago JV (1990) Randomized prospective study of self-management training with newly diagnosed diabetic children. Diabetes Care 13:492–498 (EK Ib)PubMedCrossRef

134.

Delamater AM, de Wit M, McDarby V, Malik J, Acerini CL ISPAD Clinical Practice Consensus Guidelines 2014. Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes 2014(15):232–244 (EK IV)

135.

Delamater AM, Jacobson AM, Anderson B, Cox D, Fisher L, Lustman P, Rubin R, Wysocki T (2001) Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care 24:1286–1292 (EK Ia)PubMedCrossRef

136.

Delamater AM, Shaw KH, Applegate EB, Pratt IA, Eidson M, Lancelotta GX, Gonzalez-Mendoza L, Richton S (1999) Risk for metabolic control problems in minority youth with diabetes. Diabetes Care 22:700–705 (EK III)PubMedCrossRef

137.

Delamater AM, de Wit M, McDarby V, Malik J, Acerini CL (2014) Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes 15:232–244PubMedCrossRef

138.

Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE) (Hrsg) (2015) Referenzwerte für die Nährstoffzufuhr, 2. Aufl. , Bonn (EK IV)

139.

Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE), Schweizerische Vereinigung für Ernährung (SVE) (Hrsg) (2008) Referenzwerte für die Nährstoffzufuhr. Neuer Umschau Buchverl, Neustadt/Weinstraße (EK IV)

140.

Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP). (2013) Behandlung von depressiven Störungen bei Kindern und Jugendlichen. Evidenz- und konsensbasierte Leitlinie (S3). Langfassung. http://www.awmf.org/uploads/tx_szleitlinien/028–043l_S3_Depressive_St%C3 %B6rungen_bei_Kindern_Jugendlichen_2013–07.pdf (Erstellt: 1. Juli 2013) (EK IV)

141.

Deutsche Gesellschaft für pädiatrische Rehabilitation und Prävention (2007) Leitlinie Rehabilitation Diabetes mellitus im Kindes- und Jugendalter. http://www.awmf.org/uploads/tx_szleitlinien/070-003k_S2_Diabetes_mellitus_stationaere_Rehabilitation.pdf

142.

Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2009) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 1. Aufl. Bd. 5. https://doi.org/10.6101/AZQ/000239 (EK IV)CrossRef

143.

Deutsche Hochdruckliga, Deutsche Hypertoniegesellschaft (2008) Leitlinien zur Behandlung der arteriellen Hypertonie. DHL, Heidelberg

144.

Deutsche Rentenversicherung Bund (2009) Rahmenkonzept zur medizinischen Rehabilitation in der gesetzlichen Rentenversicherung, 3. Aufl. Deutsche Rentenversicherung Bund, Berlin

145.

Diabetes Control and Complications Trial Research Group (1991) Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group. Am J Med 90:450–459 (EK III)CrossRef

146.

Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125:177–188 (EK Ib)CrossRef

147.

Diabetes Control and Complications Trial Research Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44:968–983 (EK Ib)CrossRef

148.

Diabetes Control and Complications Trial Research Group (1996) The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45:1289–1298CrossRef

149.

Diabetes Prevention Trial-Type 1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685–1691CrossRef

150.

DiMeglio LA, Acerini CL, Codner E et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 19(Suppl. 27):10–114. https://doi.org/10.1111/pedi.12737CrossRef

151.

Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD (2002) Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 87:430–431PubMedPubMedCentralCrossRef

152.

Dodson PM, Beevers M, Hallworth R, Webberley MJ, Fletcher RF, Taylor KG (1989) Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 298:227–230 (EK Ib)PubMedPubMedCentralCrossRef

153.

Doherty FM, Calam R, Sanders MR (2013) Positive parenting program (triple P) for families of adolescents with type 1 diabetes: a randomized controlled trial of self-directed teen triple P. J Pediatr Psychol 38:846–858, EK Ib

154.

Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K (2007) ISPAD clinical practice consensus guidelines 2006–2007. Microvascular and macrovascular complications. Pediatr Diabetes 8:163–170 (EK III)PubMedCrossRef

155.

Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K (2007) ISPAD clinical practice consensus guidelines 2006–2007. Microvascular and macrovascular complication. Pediatr Diabetes 8:163–170 (EK IIb)PubMedCrossRef

156.

Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K (2007) ISPAD clinical practice consensus guidelines 2006–2007. Microvascular and macrovascular complications. Pediatr Diabetes 8:163–170 (EK IV)PubMedCrossRef

157.

Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K (2007) ISPAD clinical practice consensus guidelines 2006–2007. Microvascular and macrovascular complications. Pediatr Diabetes 8:163–170PubMedCrossRef

158.

Donaghue KC, Craig ME, Chan AK, Fairchild JM, Cusumano JM, Verge CF, Crock PA, Hing SJ, Howard NJ, Silink M (2005) Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes. Diabet Med 22:711–718 (EK IIb–III)PubMedCrossRef

159.

Donaghue KC, Wadwa RP, Dimeglio LA, Wong TY, Chiarelli F, Marcovecchio ML, Salem M, Raza J, Hofman PL, Craig ME (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 15(Suppl 20):257–269 (EK IV)PubMedCrossRef

160.

Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ (2005) Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care 28:806–809 (EK IIa)PubMedCrossRef

161.

Dost A, Klinkert C, Kapellen T, Lemmer A, Naeke A, Grabert M, Kreuder J, Holl RW (2008) Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2105 children and adolescents with type 1 diabetes. Diabetes Care 31:720–725PubMedCrossRef

162.

Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI (2004) ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89:188–194 (EK IV)PubMedPubMedCentralCrossRef

163.

Edge JA, Jakes RW, Roy Y, Hawkins M, Winter D, Ford-Adams ME, Murphy NP, Bergomi A, Widmer B, Dunger DB (2006) The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 49:2002–2009 (EK II)PubMedCrossRef

164.

Edghill E, Flanagan SE, Patch AM, Boustred C, Parrish A, Shields B, Shepherd MH, Hussain K, Kapoor RR, Malecki M, MacDonald MJ, Stoy J, Steiner DF, Philipson LH, Bell GI, Hattersley AT, Ellard S (2008) Insulin mutation screening in 1044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57:1034–1042 (EK III)PubMedCrossRef

165.

Ehehalt S, Blumenstock G, Willasch AM, Hub R, Ranke MB, Neu A (2008) Continuous rise in incidence of childhood Type 1 diabetes in Germany. Diabet Med 25:755–757 (EK III)PubMedCrossRef

166.

Ehehalt S, Dietz K, Willasch AM, Neu A (2012) Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohort-dependent increase within the next two decades in Germany. Pediatr Diabetes 13:15–20 (EK III)PubMedCrossRef

167.

Ehehalt S, Gauger N, Blumenstock G, Feldhahn L, Scheffner T, Schweizer R, Neu A (2010) Hemoglobin A1c is a reliable criterion for diagnosing type 1 diabetes in childhood and adolescence. Pediatr Diabetes 11:446–449PubMedCrossRef

168.

Ellard S, Bellanne-Chantelot C, Hattersley AT (2008) Best practice guidelines for the molecular genetic diagnosis of maturityonset diabetes of the young. Diabetologia 51:546–553 (EK III)PubMedPubMedCentralCrossRef

169.

Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, Edghill EL, Mackay DJ, Proks P, Shimomura K, Haberland H, Carson DJ, Shield JP, Hattersley AT, Ashcroft FM (2007) Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet 81:375–382PubMedPubMedCentralCrossRef

170.

Ellert U, Brettschneider AK, Ravens-Sieberer U (2014) Gesundheitsbezogene Lebensqualität bei Kindern und Jugendlichen in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:798–806 (EK IIb)PubMedCrossRef

171.

Ellis D, Naar-King S, Templin T, Frey M, Cunningham P, Sheidow A, Cakan N, Idalski A (2008) Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months. Diabetes Care 31:1746–1747 (EK Ib)PubMedPubMedCentralCrossRef

172.

Ellis DA, Naar-King S, Chen X, Moltz K, Cunningham PB, Idalski-Carcone A (2012) Multisystemic therapy compared to telephone support for youth with poorly controlled diabetes: findings from a randomized controlled trial. Ann Behav Med 44:207–215 (EK Ib)PubMedCrossRef

173.

Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA (2004) Diabetes patient education: a meta-analysis and metaregression. Patient Educ Couns 52:97–105PubMedCrossRef

174.

Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ (2006) Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin 22:1013–1020 (EK III)PubMedCrossRef

175.

Erhart M, Holling H, Bettge S, Ravens-Sieberer U, Schlack R (2007) Der Kinder- und Jugendgesundheitssurvey (KiGGS): Risiken und Ressourcen für die psychische Entwicklung von Kindern und Jugendlichen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:800–809 (EK III)PubMedCrossRef

176.

European Medicines Agency (EMA) (2013) Outcome of review of new safety data on insulin glargine. http://www.ema.europa. eu/docs/en_GB/document_library/Medicine_QA/2013/05/WC500 143 823.pdf,

177.

European Society of Cardiology (2013) Leitlinien für das Management der arteriellen Hypertonie. ESC Pocket Guideline. http://leitlinien.dgk.org/files/2014_Pocket-Leitlinien_Arterielle_Hypertonie.pdf

178.

Fagot-Campagna A, Narayan KM, Imperatore G (2001) Type 2 diabetes in children. BMJ 322:377–378 (EK III)PubMedPubMedCentralCrossRef

179.

Felber J, Aust D, Baas S, Bischoff S, Blaker H, Daum S, Keller R, Koletzko S, Laass M, Nothacker M, Roeb E, Schuppan D, Stallmach A (2014) Ergebnisse einer S2k-Konsensuskonferenz der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS) gemeinsam mit der Deutschen Zöliakie-Gesellschaft (DZG) zur Zöliakie, Weizenallergie und Weizensensitivität. Z Gastroenterol 52:711–743 (EK IV)PubMedCrossRef

180.

Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T (1991) Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34:164–170PubMedCrossRef

181.

Fendler W, Baranowska AI, Mianowska B, Szadkowska A, Mlynarski W (2012) Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes. Acta Diabetol 49:363–370 (EK IIb)PubMedCrossRef

182.

Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS (2007) Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol 2:461–469 (EK IIb)PubMedCrossRef

183.

Fiordalisi I, Novotny WE, Holbert D, Finberg L, Harris GD (2007) An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes 8:142–149 (EK III)PubMedCrossRef

184.

Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT (2006) Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49:1190–1197 (EK IIb–III)PubMedCrossRef

185.

Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D, Shield JP, Temple K, Ellard S, Hattersley AT (2007) Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 56:1930–1937 (EK IIb–III)PubMedCrossRef

186.

Forsander G, Persson B, Sundelin J, Berglund E, Snellman K, Hellstrom R (1998) Metabolic control in children with insulin-dependent diabetes mellitus 5y after diagnosis. Early detection of patients at risk for poor metabolic control. Acta Paediatr 87:857–864 (EK III)PubMedCrossRef

187.

Forsander GA, Sundelin J, Persson B (2000) Influence of the initial management regimen and family social situation on glycemic control and medical care in children with type I diabetes mellitus. Acta Paediatr 89:1462–1468 (EK IIa)PubMedCrossRef

188.

Franklin B, Liu J, Ginsberg-Fellner F (1982) Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus. Pediatrics 69:87–90 (EK III)PubMedCrossRef

189.

Frost F, Dyce P, Nazareth D, Malone V, Walshaw MJ (2018) Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosisrelated diabetes. J Cyst Fibros 17(6):798–803PubMedCrossRef

190.

Fröhlich C, Hermann T, Koch S, Regling B, Schiel R, Stachow R, Holl R (2008) Indikationen für eine stationäre Rehabilitation von Kindern und Jugendlichen mit Typ-1-Diabetes – eine bundesweite „DPV-Wiss“-Analyse. Diabetes Stoffwechs 93: (EK III)

191.

Fröhlich-Reiterer EE, Hofer S, Kaspers S, Herbst A, Kordonouri O, Schwarz HP, Schober E, Grabert M, Holl RW (2008) Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus—data from a German/Austrian multicentre survey. Pediatr Diabetes 9:546–553 (EK III)PubMedCrossRef

192.

Fröhlich-Reiterer EE, Kaspers S, Hofer S, Schober E, Kordonouri O, Pozza SB, Holl RW (2011) Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease. J Pediatr 158:589–593 (EK III)PubMedCrossRef

193.

Gaede P, Vedel P, Parving HH, Pedersen O (1999) 21 Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617–622PubMedCrossRef

194.

Gage H, Hampson S, Skinner TC, Hart J, Storey L, Foxcroft D, Kimber A, Cradock S, McEvilly EA (2004) Educational and psychosocial programmes for adolescents with diabetes: approaches, outcomes and cost-effectiveness. Patient Educ Couns 53:333–346 (EK Ib)PubMedCrossRef

195.

Gale EA, Bingley PJ, Emmett CL, Collier T (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925–931 (EK Ib)PubMedCrossRef

196.

Gale EA, Gillespie KM (2001) Diabetes and gender. Diabetologia 44:3–15 (EK IIb)PubMedCrossRef

197.

Garg A (1998) High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67:577S–582S (EK Ia)PubMedCrossRef

198.

Garin I, Edghill EL, Akerman I, Rubio-Cabezas O, Rica I, Locke JM, Maestro MA, Alshaikh A, Bundak R, del Castillo G, Deeb A, Deiss D, Fernandez JM, Godbole K, Hussain K, O’Connell M, Klupa T, Kolouskova S, Mohsin F, Perlman K, Sumnik Z, Rial JM, Ugarte E, Vasanthi T, Johnstone K, Flanagan SE, Martinez R, Castano C, Patch AM, Fernandez-Rebollo E, Raile K, Morgan N, Harries LW, Castano L, Ellard S, Ferrer J, de Perez NG, Hattersley AT (2010) Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci U S A 107:3105–3110PubMedPubMedCentralCrossRef

199.

Gaudieri PA, Chen R, Greer TF, Holmes CS (2008) Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care 31:1892–1897 (EK Ib)PubMedPubMedCentralCrossRef

200.

Gayes LA, Steele RG (2014) A meta-analysis of motivational interviewing interventions for pediatric health behavior change. J Consult Clin Psychol 82:521–535 (EK Ia)PubMedCrossRef

201.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef

202.

Gerstl EM, Rabl W, Rosenbauer J, Grobe H, Hofer SE, Krause U, Holl RW (2008) Metabolic control as reflected by HbA1c in children, adolescents and young adults with type‑1 diabetes mellitus: combined longitudinal analysis including 27035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 167:447–453, EK IIb–III

203.

Gheissari A, Javanmard SH, Shirzadi R, Amini M, Khalili N (2012) The effects of blocking Angiotensin receptors on early stages of diabetic nephropathy. Int J Prev Med 3:477–482PubMedPubMedCentral

204.

Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D’Episcopo L, Riccardi G (2000) Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 23:1461–1466 (EK Ib)PubMedCrossRef

205.

Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, Kaufman F, Quayle K, Roback M, Malley R, Kuppermann N (2001) Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 344:264–269 (EK III)PubMedCrossRef

206.

Glaser NS, Wootton-Gorges SL, Buonocore MH, Marcin JP, Rewers A, Strain J, DiCarlo J, Neely EK, Barnes P, Kuppermann N (2006) Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes 7:75–80 (EK III)PubMedCrossRef

207.

Glasgow RE, Fisher EB, Anderson BJ, LaGreca A, Marrero D, Johnson SB, Rubin RR, Cox DJ (1999) Behavioral science in diabetes. Contributions and opportunities. Diabetes Care 22:832–843 (EK Ia)PubMedCrossRef

208.

Gloyn AL, Diatloff-Zito C, Edghill EL, Bellanne-Chantelot C, Nivot S, Coutant R, Ellard S, Hattersley AT, Robert JJ (2006) KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14:824–830PubMedCrossRef

209.

Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838–1849 (EK III)PubMedCrossRef

210.

Goebel-Fabbri AE, Fikkan J, Franko DL, Pearson K, Anderson BJ, Weinger K (2008) Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care 31:415–419 (EK IIb)PubMedCrossRef

211.

Golicki DT, Golicka D, Groele L, Pankowska E (2008) Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 51:233–240 (EK Ia)PubMedCrossRef

212.

Gong M, Simaite D, Kuhnen P, Heldmann M, Spagnoli F, Blankenstein O, Hubner N, Hussain K, Raile K (2013) Two novel GATA6 mutations cause childhood-onset diabetes mellitus, pancreas malformation and congenital heart disease. Horm Res Paediatr 79:250–256PubMedCrossRef

213.

Gottschalk M, Danne T, Vlajnic A, Cara JF (2007) Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care 30:790–794 (EK Ib)PubMedCrossRef

214.

Grabert M, Schweiggert F, Holl RW (2002) A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Programs Biomed 69:115–121 (EK III)PubMedCrossRef

215.

Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La GL, Gurwitz JH, Chan KA, Goodman MJ, Platt R (2004) Incidence of hospitalized rhabdomyolysis in patients treated with lipidlowering drugs. JAMA 292:2585–2590 (EK III)PubMedCrossRef

216.

Green SM, Rothrock SG, Ho JD, Gallant RD, Borger R, Thomas TL, Zimmerman GJ (1998) Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med 31:41–48PubMedCrossRef

217.

Grey M, Boland EA, Davidson M, Li J, Tamborlane WV (2000) Coping skills training for youth with diabetes mellitus has longlasting effects on metabolic control and quality of life. J Pediatr 137:107–113 (EK Ib)PubMedCrossRef

218.

Grey M, Cameron ME, Lipman TH, Thurber FW (1995) Psychosocial status of children with diabetes in the first 2 years after diagnosis. Diabetes Care 18:1330–1336 (EK IIb)PubMedCrossRef

219.

Grey M, Cameron ME, Lipman TH, Thurber FW (1995) Psychosocial status of children with diabetes in the first 2 years after diagnosis. Diabetes Care 18:1330–1336 (EK III)PubMedCrossRef

220.

Grey M, Whittemore R, Jaser S, Ambrosino J, Lindemann E, Liberti L, Northrup V, Dziura J (2009) Effects of coping skills training in school-age children with type 1 diabetes. Res Nurs Health 32:405–418 (EK Ib)PubMedPubMedCentralCrossRef

221.

Grey M, Whittemore R, Jeon S, Murphy K, Faulkner MS, Delamater A (2013) Internet psycho-education programs improve outcomes in youth with type 1 diabetes. Diabetes Care 36:2475–2482 (EK Ib)PubMedPubMedCentralCrossRef

222.

Grulich-Henn J, Wagner V, Thon A, Schober E, Marg W, Kapellen TM, Haberland H, Raile K, Ellard S, Flanagan SE, Hattersley AT, Holl RW (2010) Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med 27:709–712 (EK III)PubMedCrossRef

223.

Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, Fisher EB, Hanson L, Kent D, Kolb L, McLaughlin S, Orzeck E, Piette JD, Rhinehart AS, Rothman R, Sklaroff S, Tomky D, Youssef G (2014) National standards for diabetes self-management education and support. Diabetes Care 37(Suppl 1):S144–S153PubMedCrossRef

224.

Hale PJ, Crase J, Nattrass M (1984) Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J 289:1035–1038 (EK IIa)CrossRef

225.

Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW (2011) Diabetic retinopathy in type 1 diabetes‑a contemporary analysis of 8784 patients. Diabetologia 54:1977–1984PubMedCrossRef

226.

Hampson SE, Skinner TC, Hart J, Storey L, Gage H, Foxcroft D, Kimber A, Shaw K, Walker J (2001) Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess 5:1–79 (EK Ia)PubMedCrossRef

227.

Hanas R, Adolfsson P (2006) Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 7:25–31, EK III

228.

Hanas R, Lindgren F, Lindblad B (2007) Diabetic ketoacidosis and cerebral oedema in Sweden—a 2‑year paediatric population study. Diabet Med 24:1080–1085 (EK III)PubMedCrossRef

229.

Hanberger L, Ludvigsson J, Nordfeldt S (2013) Use of a web 2.0 portal to improve education and communication in young patients with families: randomized controlled trial. J Med Internet Res 15:e175 (EK Ib)PubMedPubMedCentralCrossRef

230.

Hansen D, Brock-Jacobsen B, Lund E, Bjorn C, Hansen LP, Nielsen C, Fenger C, Lillevang ST, Husby S (2006) Clinical benefit of a gluten-free diet in type 1 diabetic children with screeningdetected celiac disease: a population-based screening study with 2 years follow-up. Diabetes Care 29:2452–2456 (EK IIa)PubMedCrossRef

231.

Harris MA, Freeman KA, Beers M (2009) Family therapy for adolescents with poorly controlled diabetes: initial test of clinical significance. J Pediatr Psychol 34:1097–1107 (EK IIb)PubMedPubMedCentralCrossRef

232.

Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K (2006) ISPAD Clinical Practice Consensus Guidelines 2006–2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 7:352–360 (EK IV)PubMedCrossRef

233.

Haugstvedt A, Wentzel-Larsen T, Graue M, Sovik O, Rokne B (2010) Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med 27:72–78 (EK IIb)PubMedCrossRef

234.

Haugstvedt A, Wentzel-Larsen T, Rokne B, Graue M (2011) Perceived family burden and emotional distress: similarities and differences between mothers and fathers of children with type 1 diabetes in a population-based study. Pediatr Diabetes 12:107–114 (EK IIb)PubMedCrossRef

235.

Hecker W, Bartus B, Heinze E, Holl RW (1998) Stoffwechseleinstellung des Diabetes mellitus Typ 1 bei Kindern und Jugendlichen deutscher und ausländischer Herkunft. Diabetes Stoffwechs 5:177–180 (EK III)

236.

Hecker W, Grabert M, Holl RW (1999) Quality of paediatric IDDM care in Germany: a multicentre analysis. German Paediatric Diabetology Group. J Pediatr Endocrinol Metab 12:31–38 (EK III)PubMedCrossRef

237.

Helgeson VS, Reynolds KA, Becker D, Escobar O, Siminerio L (2014) Relations of behavioral autonomy to health outcomes among emerging adults with and without type 1 diabetes. J Pediatr Psychol 39:1126–1137 (EK III)PubMedPubMedCentralCrossRef

238.

Helgeson VS, Siminerio L, Escobar O, Becker D (2009) Predictors of metabolic control among adolescents with diabetes: a 4-year longitudinal study. J Pediatr Psychol 34:254–270 (EK III)PubMedCrossRef

239.

Helgeson VS, Snyder PR, Escobar O, Siminerio L, Becker D (2007) Comparison of adolescents with and without diabetes on indices of psychosocial functioning for three years. J Pediatr Psychol 32:794–806 (EK IIb)PubMedCrossRef

240.

Helgeson VS, Viccaro L, Becker D, Escobar O, Siminerio L (2006) Diet of adolescents with and without diabetes: Trading candy for potato chips? Diabetes Care 29:982–987 (EK III)PubMedCrossRef

241.

Hellems MA, Clarke WL (2007) Safe at school: a Virginia experience. Diabetes Care 30:1396–1398 (EK III)PubMedCrossRef

242.

Hermann JM, Hammes HP, Rami-Merhar B, Rosenbauer J, Schutt M, Siegel E, Holl RW (2014) HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35 891 patients. PLoS ONE 9:e91137PubMedPubMedCentralCrossRef

243.

Herzer M, Hood KK (2010) Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control. J Pediatr Psychol 35:415–425 (EK III)PubMedCrossRef

244.

Herzer M, Vesco A, Ingerski LM, Dolan LM, Hood KK (2011) Explaining the family conflict-glycemic control link through psychological variables in adolescents with type 1 diabetes. J Behav Med 34:268–274 (EK III)PubMedCrossRef

245.

Hieftje K, Edelman EJ, Camenga DR, Fiellin LE (2013) Electronic media-based health interventions promoting behavior change in youth: a systematic review. JAMA Pediatr 167:574–580 (EK Ia)PubMedPubMedCentralCrossRef

246.

Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG (2005) Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40:1–19 (EK III)PubMedCrossRef

247.

Hilliard ME, Herzer M, Dolan LM, Hood KK (2011) Psychological screening in adolescents with type 1 diabetes predicts outcomes one year later. Diabetes Res Clin Pract 94:39–44 (EK III)PubMedPubMedCentralCrossRef

248.

Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA (2008) Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 10:377–383 (EK Ib)PubMedCrossRef

249.

Hoey H (2009) Psychosocial factors are associated with metabolic control in adolescents: research from the Hvidoere Study Group on Childhood Diabetes. Pediatr Diabetes 10(Suppl 13):9–14 (EK IIb)PubMedCrossRef

250.

Holl RW, Grabert M (2015) Versorgung von Kindern und Jugendlichen mit Diabetes – Entwicklungen der letzten 19 Jahre. In: Gesundheitsbericht Diabetes 2015 (Hrsg) Deutsche Diabetes-Hilfe, S 128–138 (EK III)

251.

Holl RW, Grabert M, Heinze E, Sorgo W, Debatin KM (1998a) Age at onset and long-term metabolic control affect height in type‑1 diabetes mellitus. Eur J Pediatr 157:972–977 (EK III)PubMedCrossRef

252.

Holl RW, Heinze E (1992) Dawn- oder Somogyi-Phänomen? Hohe morgendliche Nüchternblutzuckerwerte bei jugendlichen Typ-1-Diabetikern. Dtsch Med Wochenschr 117:1503–1507 (EK III)PubMedCrossRef

253.

Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM (1998b) Diabetic retinopathy in pediatric patients with type‑1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr 132:790–794 (EK III)PubMedCrossRef

254.

Holl RW, Pavlovic M, Heinze E, Thon A (1999) Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care 22:1151–1157, EK III

255.

Holl RW, Wolf A, Heinze E, Teller WM (1997) Nicht-immunologisch bedingte Formen des Diabetes mellitus bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 145:159–176 (EK III)

256.

Hölling H, Erhart M, Ravens-Sieberer U, Schlack R (2007a) Verhaltensauffälligkeiten bei Kindern und Jugendlichen. Erste Ergebnisse aus dem Kinder- und Jugendgesundheitssurvey (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:784–793 (EK III)PubMedCrossRef

257.

Hölling H, Schlack R (2007b) Essstörungen im Kindes- und Jugendalter. Erste Ergebnisse aus dem Kinder- und Jugendgesundheitssurvey (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:794–799 (EK III)PubMedCrossRef

258.

Hölling H, Schlack R, Petermann F, Ravens-Sieberer U, Mauz E (2014) Psychische Auffälligkeiten und psychosoziale Beeinträchtigungen bei Kindern und Jugendlichen im Alter von 3 bis 17 Jahren in Deutschland – Prävalenz und zeitliche Trends zu 2 Erhebungszeitpunkten (2003–2006 und 2009–2012). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:807–819 (EK IIb)PubMedCrossRef

259.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589 (EK Ib)PubMedCrossRef

260.

Holmes CS, Chen R, Streisand R, Marschall DE, Souter S, Swift EE, Peterson CC (2006) Predictors of youth diabetes care behaviors and metabolic control: a structural equation modeling approach. J Pediatr Psychol 31:770–784 (EK III)PubMedCrossRef

261.

Holterhus PM, Odendahl R, Oesingmann S, Lepler R, Wagner V, Hiort O, Holl R (2007) Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy. Diabetes Care 30:568–573 (EK IIb–III)PubMedCrossRef

262.

Hommel E, Olsen B, Battelino T, Conget I, Schutz-Fuhrmann I, Hoogma R, Schierloh U, Sulli N, Gough H, Castaneda J, de Porto S, Bolinder J (2014) Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 51:845–851 (EK Ib)PubMedPubMedCentralCrossRef

263.

Hood KK, Huestis S, Maher A, Butler D, Volkening L, Laffel LM (2006) Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care 29:1389–1391 (EK III)PubMedCrossRef

264.

Hood KK, Rausch JR, Dolan LM (2011) Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change. Pediatr Diabetes 12:718–723 (EK III)PubMedCrossRef

265.

Hood KK, Rohan JM, Peterson CM, Drotar D (2010) Interventions with adherence-promoting components in pediatric type 1 diabetes: meta-analysis of their impact on glycemic control. Diabetes Care 33:1658–1664 (EK Ia)PubMedPubMedCentralCrossRef

266.

Horsch A, McManus F, Kennedy P, Edge J (2007) Anxiety, depressive, and posttraumatic stress symptoms in mothers of children with type 1 diabetes. J Trauma Stress 20:881–891 (EK III)PubMedCrossRef

267.

Hovorka R, Elleri D, Thabit H, Allen JM, Leelarathna L, El-Khairi R, Kumareswaran K, Caldwell K, Calhoun P, Kollman C, Murphy HR, Acerini CL, Wilinska ME, Nodale M, Dunger DB (2014) Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 37:1204–1211 (EK Ib)PubMedPubMedCentralCrossRef

268.

Howell WH, McNamara DJ, Tosca MA, Smith BT, Gaines JA (1997) Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 65:1747–1764 (EK Ia)PubMedCrossRef

269.

Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE (2003) Fish and long-chain omega‑3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107:1852–1857 (EK III)PubMedCrossRef

270.

Hürter A, Otten A (1991) Familien mit diabetischen Kindern und Jugendlichen: Psychische und soziale Probleme und der Wunsch nach psychologischer Hilfe im Vergleich mit anderen chronischen Erkrankungen. In: Roth R, Borkenstein M (Hrsg) Psychosoziale Aspekte in der Betreuung von Kindern und Jugendlichen mit Diabetes. Karger, Basel, S 150–159 (EK III)

271.

Hürter P, Bürger W, Schober E, Holl R, Klinghammer A (1995) Qualitätssicherung in der Pädiatrischen Diabetologie. Monatsschr Kinderheilkd 143:1146–1149 (EK IV)

272.

Hürter P, von Schütz W, Lange K (2012) Kinder und Jugendliche mit Diabetes. Medizinischer und psychologischer Ratgeber für Eltern, 3. Aufl. Springer, BerlinCrossRef

273.

Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Maki M, Ribes-Koninckx C, Ventura A, Zimmer KP (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54:136–160 (EK IV)PubMedCrossRef

274.

Hutchinson A, McIntosh A, Peters J, O’Keeffe C, Khunti K, Baker R, Booth A (2000) Effectiveness of screening and monitoring tests for diabetic retinopathy—a systematic review. Diabet Med 17:495–506 (EK IIa)PubMedCrossRef

275.

Icks A, Razum O, Rosenbauer J, Bachle C, Hungele A, Monkemoller K, Muller-Godeffroy E, Heidtmann B, Kapellen T, Scheuing N, Holl RW (2012) Lower frequency of insulin pump treatment in children and adolescents of Turkish background with type 1 diabetes: analysis of 21 497 patients in Germany. Diabetes Technol Ther 14:1105–1109 (EK IIb)PubMedPubMedCentralCrossRef

276.

Icks A, Rosenbauer J, Holl RW, Giani G (2001) Increased hospitalization with longer distance from treatment centre in diabetic paediatric patients in Germany. Diabetologia 44:1068–1069 (EK IIb–III)PubMedCrossRef

277.

Icks A, Rosenbauer J, Strassburger K, Grabert M, Giani G, Holl RW (2007) Persistent social disparities in the risk of hospital admission of paediatric diabetic patients in Germany-prospective data from 1277 diabetic children and adolescents. Diabet Med 24:440–442 (EK III)PubMedCrossRef

278.

Ingerski LM, Laffel L, Drotar D, Repaske D, Hood KK (2010) Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes. Pediatr Diabetes 11:563–571 (EK III)PubMedCrossRef

279.

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) (2007) Kurzwirksame Insulinanaloga zur Behandlung des Diabetes mellitus Typ 1. Abschlussbericht. Auftrag A05–02. Version 1.0. Stand: 30.03.2007, IQWiG, Köln

280.

International Hypoglycaemia Study Group (2017) Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 40:155–157CrossRef

281.

International Society for Pediatric and Adolescent Diabetes (2014) Clinical Practice Consensus Guidelines 2014. Pediatr Diabetes 15:1–290CrossRef

282.

Irgens HU, Molnes J, Johansson BB, Ringdal M, Skrivarhaug T, Undlien DE, Sovik O, Joner G, Molven A, Njolstad PR (2013) Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry. Diabetologia 56:1512–1519PubMedCrossRef

283.

Jacobson AM, Hauser ST, Lavori P, Willett JB, Cole CF, Wolfsdorf JI, Dumont RH, Wertlieb D (1994) Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med 56:401–409 (EK III)PubMedCrossRef

284.

Jacobson AM, Hauser ST, Willett J, Wolfsdorf JI, Herman L (1997) Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr 131:727–733 (EK III)PubMedCrossRef

285.

Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J (2007) Longterm effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842–1852 (EK Ib)PubMedCrossRef

286.

Janner M, Knill SE, Diem P, Zuppinger KA, Mullis PE (1994) Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study. Eur J Pediatr 153:403–408 (EK IIb)PubMedCrossRef

287.

Jefferies C, Solomon M, Perlman K, Sweezey N, Daneman D (2005) Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 147:396–398 (EK IIb)PubMedCrossRef

288.

Jefferson IG, Swift PG, Skinner TC, Hood GK (2003) Diabetes services in the UK: third national survey confirms continuing deficiencies. Arch Dis Child 88:53–56 (EK III)PubMedPubMedCentralCrossRef

289.

Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A (2008) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 51:941–951 (Ia)PubMedCrossRef

290.

Johansson S, Irgens H, Chudasama KK, Molnes J, Aerts J, Roque FS, Jonassen I, Levy S, Lima K, Knappskog PM, Bell GI, Molven A, Njolstad PR (2012) Exome sequencing and genetic testing for MODY. Plos One 7:e38050PubMedPubMedCentralCrossRef

291.

Jones CA, Leese GP, Kerr S, Bestwick K, Isherwood DI, Vora JP, Hughes DA, Smith C (1998) Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child 78:518–523 (EK III)PubMedPubMedCentralCrossRef

292.

Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ (2002) Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25:89–94 (EK Ib)PubMedCrossRef

293.

Kalk WJ, Osler C, Constable J, Kruger M, Panz V (1992) Influence of dietary protein on glomerular filtration and urinary albumin excretion in insulin-dependent diabetes. Am J Clin Nutr 56:169–173 (EK III)PubMedCrossRef

294.

Kapellen T, Vogel C, Telleis D, Siekmeyer M, Kiess W (2012) Treatment of diabetic ketoacidosis (DKA) with 2 different regimens regarding fluid substitution and insulin dosage (0.025 vs. 0.1 units/kg/h). Exp Clin Endocrinol Diabetes 120:273–276 (EK III)PubMedCrossRef

295.

Kapellen TM, Klinkert C, Heidtmann B, Jakisch B, Haberland H, Hofer SE, Holl RW (2010) Insulin pump treatment in children and adolescents with type 1 diabetes: experiences of the German working group for insulin pump treatment in pediatric patients. Postgrad Med 122:98–105PubMedCrossRef

296.

Karges B, Muche R, Knerr I, Ertelt W, Wiesel T, Hub R, Neu A, Klinghammer A, Aufschild J, Rapp A, Schirbel A, Boehm BO, Debatin KM, Heinze E, Karges W (2007) Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial. J Clin Endocrinol Metab 92:1647–1652 (EK Ib)PubMedCrossRef

297.

Karges B, Rosenbauer J, Holterhus PM, Beyer P, Seithe H, Vogel C, Bockmann A, Peters D, Muther S, Neu A, Holl RW (2015) Hospital admission for diabetic ketoacidosis or severe hypoglycemia in 31 330 young patients with type 1 diabetes. Eur J Endocrinol 173:341–350 (EK III)PubMedCrossRef

298.

Karges B, Rosenbauer J, Kapellen T, Wagner VM, Schober E, Karges W, Holl RW (2014) Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37 539 patients between 1995 and 2012. PLoS Med 11:e1001742 (EK III)PubMedPubMedCentralCrossRef

299.

Karges B, Schwandt A, Heidtmann B et al (2017) Association of Insulin Pump Therapy vs. Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA 318(14):1358–1366. https://doi.org/10.1001/jama.2017.13994CrossRefPubMedPubMedCentral

300.

Katan MB, Zock PL, Mensink RP (1995) Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr 61:1368S–1373S (EK Ia)PubMedCrossRef

301.

Katz ML, Volkening LK, Butler DA, Anderson BJ, Laffel LM (2014) Family-based psychoeducation and Care Ambassador intervention to improve glycemic control in youth with type 1 diabetes: a randomized trial. Pediatr Diabetes 15:142–150 (EK Ib)PubMedCrossRef

302.

Keane S, Gallagher A, Ackroyd S, McShane MA, Edge JA (2002) Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child 86:204–205 (EK IV)PubMedPubMedCentralCrossRef

303.

Kellerer M, Danne T (2010) Praxis-Leitlinien der Deutschen Diabetes Gesellschaft. Diabetes Stoffwechs 5:S107–S108CrossRef

304.

Kellerer M, Siegel E, (Hrsg). Praxisleitlinien der Deutschen Diabetes Gesellschaft. Diabet Stoffw 2014; 9: S95–S228

305.

Kempf K, Rathmann W, Herder C (2008) Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab Res Rev 24:427–437 (EK IIb–III)PubMedCrossRef

306.

Kiess W, Bottner A, Raile K, Kapellen T, Muller G, Galler A, Paschke R, Wabitsch M (2003) Type 2 diabetes mellitus in children and adolescents: a review from a European perspective. Horm Res 59(Suppl 1):77–84, EK III

307.

Kilpatrick ES, Rigby AS, Atkin SL (2006) The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29:1486–1490 (EK IIa)PubMedCrossRef

308.

Kintzel R, Holl R, Haberland H, Grabert M, Dost A (2003) Die diabetische Ketoazidose bei Erkrankungsbeginn im Kindes- und Jugendalter in der Bundesrepublik. Diabetes Stoffwechs 12:8–12 (EK IIb)

309.

Klupa T, Kowalska I, Wyka K, Skupien J, Patch AM, Flanagan SE, Noczynska A, Arciszewska M, Ellard S, Hattersley AT, Sieradzki J, Mlynarski W, Malecki MT (2008) Mutations in the ABCC8 gene are associated with a variable clinical phenotype. Clin Endocrinol : (EK III)

310.

Knerr I, Dost A, Lepler R, Raile K, Schober E, Rascher W, Holl RW (2008) Tracking and prediction of arterial blood pressure from childhood to young adulthood in 868 patients with type 1 diabetes: a multicenter longitudinal survey in Germany and Austria. Diabetes Care 31:726–727 (EK IIb–III)PubMedCrossRef

311.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403 (EK Ib)PubMedCrossRef

312.

Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B (2001) Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32:343–350 (EK III)PubMedCrossRef

313.

Koletzko B, Broekaert I, Kreuder J, Cremer P, Schwab O (2007) Leitlinien zur Diagnostik und Therapie von Hyperlipidämien bei Kindern und Jugendlichen. APS,

314.

Kongkaew C, Jampachaisri K, Chaturongkul CA, Scholfield CN (2014) Depression and adherence to treatment in diabetic children and adolescents: a systematic review and meta-analysis of observational studies. Eur J Pediatr 173:203–212 (EK Ia)PubMedCrossRef

315.

Konrad K, Scheuing N, Badenhoop K, Borkenstein MH, Gohlke B, Schofl C, Seufert J, Thon A, Holl RW (2013) Cystic fibrosis-related diabetes compared with type 1 and type 2 diabetes in adults. Diabetes Metab Res Rev 29:568–575PubMed

316.

Konrad K, Thon A, Fritsch M, Frohlich-Reiterer E, Lilienthal E, Wudy SA, Holl RW (2013) Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry. Diabetes Care 36:879–886 (EK III)PubMedPubMedCentralCrossRef

317.

Kordonouri O, Biester T, Schnell K, Hartmann R, Tsioli C, Fath M, Datz N, Danne T (2015) Lipoatrophy in children with type 1 diabetes: an increasing incidence? J Diabetes Sci Technol 9:206–208 (EK III)PubMedCrossRef

318.

Kordonouri O, Charpentier N, Hartmann R (2011) GADA positivity at onset of type 1 diabetes is a risk factor for the development of autoimmune thyroiditis. Pediatr Diabetes 12:31–33 (EK IIb)PubMedCrossRef

319.

Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A (2002a) Predictivity of thyroid autoantibodies for the de-velopment of thyroid disorders in children and adolescents with Type 1 diabetes. Diabet Med 19:518–521 (EK III)PubMedCrossRef

320.

Kordonouri O, Hartmann R, Lauterborn R, Barnekow C, Hoeffe J, Deiss D (2006) Age-specific advantages of continuous subcutaneous insulin infusion as compared with multiple daily injections in pediatric patients: one-year follow-up comparison by matched-pair analysis. Diabetes Care 29:133–134 (EK IIa)PubMedCrossRef

321.

Kordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PS, Craig ME ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes-associated conditions in children and adolescents. Pediatr Diabetes 2014(15):270–278 (EK IV)

322.

Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW (2002b) Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 25:1346–1350 (EK III)PubMedCrossRef

323.

Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, Donaghue K (2011) Other complications and associated conditions. In: International Diabetes Federation (IDF) (Hrsg) Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence Brussels, S 124–128 (EK IV)

324.

Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, Donaghue KC (2007) ISPAD Clinical Practice Consensus Guidelines 2006–2007. Other complications and associated conditions. Pediatr Diabetes 8:171–176PubMedCrossRef

325.

Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, Holl RW, Donaghue KC (2007) ISPAD Clinical Practice Consensus Guidelines 2006–2007. Other complications and associated conditions. Pediatr Diabetes 8:171–176 (EK IV)PubMedCrossRef

326.

Korhonen T, Huttunen JK, Aro A, Hentinen M, Ihalainen O, Majander H, Siitonen O, Uusitupa M, Pyorala K (1983) A controlled trial on the effects of patient education in the treatment of insulin-dependent diabetes. Diabetes Care 6:256–261 (EK Ib)PubMedCrossRef

327.

Koster JC, Cadario F, Peruzzi C, Colombo C, Nichols CG, Barbetti F (2008) The G53 D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J Clin Endocrinol Metab 93:1054–1061 (EK III)PubMedCrossRef

328.

Kovacs M, Feinberg TL, Paulauskas S, Finkelstein R, Pollock M, Crouse-Novak M (1985) Initial coping responses and psychosocial characteristics of children with insulin-dependent diabetes mellitus. J Pediatr 106:827–834 (EK III)PubMedCrossRef

329.

Kovacs M, Ho V, Pollock MH (1995) Criterion and predictive validity of the diagnosis of adjustment disorder: a prospective study of youths with new-onset insulin-dependent diabetes mellitus. Am J Psychiatry 152:523–528 (EK III)PubMedCrossRef

330.

Kovacs M, Iyengar S, Goldston D, Obrosky DS, Stewart J, Marsh J (1990) Psychological functioning among mothers of children with insulin-dependent diabetes mellitus: a longitudinal study. J Consult Clin Psychol 58:189–195 (EK III)PubMedCrossRef

331.

Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J (2001) Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 149:807–818, EK III

332.

Kulzer B, Albus C, Herpertz S, Kruse J, Lange K, Lederbogen F, Petrak F (2013a) Psychosoziales und Diabetes (Teil 1). S2-Leitlinie Psychosoziales und Diabetes – Langfassung. Diabetes Stoffwechs 8:198–242 (EK IV)

333.

Kulzer B, Albus C, Herpertz S, Kruse J, Lange K, Lederbogen F, Petrak F (2013b) Psychosoziales und Diabetes (Teil 2). S2-Leitlinie Psychosoziales und Diabetes – Langfassung. Diabetes Stoffwechs 8:292–324 (EK IV)

334.

Kurth BM, Schaffrath RA (2007) Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland. Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:736–743 (EK III)PubMedCrossRef

335.

l’Allemand D, Wiegand S, Reinehr T, Muller J, Wabitsch M, Widhalm K, Holl R (2008) Cardiovascular risk in 26 008 European overweight children as established by a multicenter database. Obesity 16:1672–1679 (EK IIb–III)CrossRef

336.

Laffel LM, Limbert C, Phelan H, Virmani A, Wood J, Hofer SE (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children andadolescents with diabetes. Pediatr Diabetes 19(Suppl. 27):193–204. https://doi.org/10.1111/pedi.12741CrossRefPubMed

337.

Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ (2003) Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 142:409–416 (EK IIb)PubMedCrossRef

338.

Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ (2003) Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 142:409–416 (EK IIa)PubMedCrossRef

339.

Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S (2006) Sick day management using blood 3‑hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med 23:278–284 (EK Ib)PubMedCrossRef

340.

Laguna TA, Nathan BM, Moran A (2010) Managing diabetes in cystic fibrosis. Diabetes Obes Metab 12:858–864 (EK IV)PubMedCrossRef

341.

Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H (1998) The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes 47:980–984 (EK Ib)PubMedCrossRef

342.

Landolt MA, Ribi K, Laimbacher J, Vollrath M, Gnehm HE, Sennhauser FH (2002) Posttraumatic stress disorder in parents of children with newly diagnosed type 1 diabetes. J Pediatr Psychol 27:647–652 (EK III)PubMedCrossRef

343.

Lange K, Burger W, Holl R, Hürter P, Sassmann H, von Schütz W, Danne T (2009) Diabetes bei Jugendlichen: ein Schulungsprogramm. Mainz, Kirchheim

344.

Lange K, Danne T, Kordonouri O, Berndt V, Muller B, Schwarz HP, Hesse V, Busse-Widmann P (2004) Diabetesmanifestation im Kindesalter: Alltagsbelastungen und berufliche Entwicklung der Eltern. Dtsch Med Wochenschr 129:1130–1134 (EK III)PubMedCrossRef

345.

Lange K, Hildebrandt S, Danne T Diabetesversorgung in der Pädiatrie – Leitlinien und Realität. Ergebnisse zweier bundesweiter Umfragen von 1998 und 2003. Dtsch Arztebl 2007(104):A-2121–A-2126 (EK III)

346.

Lange K, Hürter P (1998) Effekte einer strukturierten Diabetesschulung für Jugendliche auf Stoffwechsel, Wissen, Wohlbefinden und Selbständigkeit – Ergebnisse einer multizentrischen Studie. Diabetes Stoffwechs 7:62 (EK IIb)

347.

Lange K, Kinderling S, Hürter P (2001) Eine multizentrische Studie zur Prozess- und Ergebnisqualität eines strukturierten Schulungsprogramms. Diabetes Stoffwechs 10:59–65 (EK III)

348.

Lange K, Kleine T, Danne T (2011) Initialschulung für Eltern von Kindern mit Diabetes: Aufwand und Effekte bei Kindern und Eltern. Dtsch Med Wochenschr 136:1106–1110 (EK IIb)PubMedCrossRef

349.

Lange K, Klotmann S, Sassmann H, Aschemeier B, Wintergerst E, Gerhardsson P, Kordonouri O, Szypowska A, Danne T (2012) A pediatric diabetes toolbox for creating centres of reference. Pediatr Diabetes 13:49–61 (EK IV)PubMedCrossRef

350.

Lange K, Matthaei S, Lueg A, Lutze B, Roelver KM (2013) Life chances (“Lebenschancen”) of young adults with onset of type 1 diabetes during Childhood. Pediatr Diabetes 14:35 (EK IIb)

351.

Lange K, Remus K, Bläsig S, Lösch-Binder M, Neu A, von Schütz W (2013) Diabetes bei Kindern: ein Behandlungs- und Schulungsprogramm. Mainz, Kirchheim

352.

Lange K, Stachow U, Kurzinsky R, Holl R, Hürter P (2002) Pädiatrische Betreuung von Kindern und Jugendlichen mit Diabetes. Eine bundesweite Umfrage der Arbeitsgemeinschaft für Pädiatrische Diabetologie in der Deutschen Diabetes-Gesellschaft und der Deutschen Gesellschaft für Kinderheilkunde und Jugendmedizin. Diabet Stoffw 11:14–22 (EK III)

353.

Lange K, Swift P, Pankowska E, Danne T (2014a) Diabetes education in children and adolescents. Pediatr Diabetes 15:77–85 (EK IV)PubMedCrossRef

354.

Lange K, Swift P, Pankowska E, Danne T (2014b) ISPAD Clinical Practice Consensus Guidelines 2014. Diabetes education in children and adolescents. Pediatr Diabetes 15(Suppl 20):77–85 (EK IV)PubMedCrossRef

355.

Lange K, von Schütz W, Neu A, Lösch-Binder M, Remus K, Bläsig S, Sassmann H (2014) Diabetesschulung. Schulungsprogramme und Curricula für Kinder, Jugendliche mit Typ 1 Diabetes, deren Eltern und andere Betreuer. Pabst, Lengerich

356.

Lango Allen H, Flanagan SE, Shaw-Smith C, De Franco E, Akerman I, Caswell R, Ferrer J, Hattersley AT, Ellard S (2012) GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet 44:20–22CrossRef

357.

Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C (1994) Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83:72–77 (EK IIb–III)PubMedCrossRef

358.

Lanng S, Thorsteinsson B, Nerup J, Koch C (1992) Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151:684–687 (EK III)PubMedCrossRef

359.

Laron Z, Galatzer A, Amir S, Gil R, Karp M, Mimouni M (1979) A multidisciplinary, comprehensive, ambulatory treatment scheme for diabetes mellitus in children. Diabetes Care 2:342–348, EK III

360.

Larsson K, Carlsson A, Cederwall E, Jonsson B, Neiderud J, Jonsson B, Lernmark A, Ivarsson SA (2008) Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes 9:354–359 (EK IIb)PubMedCrossRef

361.

Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE (2006) Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 117:1348–1358 (EK IIb)PubMedCrossRef

362.

Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE (2006) Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics 117:1348–1358 (EK IV)PubMedCrossRef

363.

Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B (2014) 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 3:76–94 (EK IV)PubMedPubMedCentralCrossRef

364.

Lehmkuhl HD, Storch EA, Cammarata C, Meyer K, Rahman O, Silverstein J, Malasanos T, Geffken G (2010) Telehealth behavior therapy for the management of type 1 diabetes in adolescents. J Diabetes Sci Technol 4:199–208 (EK Ib)PubMedPubMedCentralCrossRef

365.

Levene LS, McNally PG, Fraser RC, Lowy AGJ (2004) What characteristics are associated with screening positive for microalbuminuria in patients with diabetes in the community? Pract Diabet Int 21:287–292 (EK III)CrossRef

366.

Levin DL (2008) Cerebral edema in diabetic ketoacidosis. Pediatr Crit Care Med 9:320–329 (EK III)PubMedCrossRef

367.

Levy-Marchal C, Patterson CC, Green A (2001) Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia 44(Suppl 3):B75–B80 (EK III)PubMedCrossRef

368.

Levy-Shraga Y, Elisha N, Ben-Ami M, Boyko V, Lerner-Geva L, Ziv T, Konvalina N, Cohen O, Pinhas-Hamiel O (2015) Glycemic control and clinic attendance of emerging adults with type 1 diabetes at a transition care clinic. Acta Diabetol. https://doi.org/10.1007/s00592-015-0734-z (EK III)CrossRefPubMed

369.

Lewis HM, Renaula TL, Garioch JJ, Leonard JN, Fry JS, Collin P, Evans D, Fry L (1996) Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 135:363–367 (EK IIa)PubMedCrossRef

370.

Liberatore RR Jr., Barbosa SF, Alkimin MG, Bellinati-Pires R, Florido MP, Isaac L, Kirschfink M, Grumach AS (2005) Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 6:206–212 (EK III)PubMedCrossRef

371.

Lin A, Northam EA, Rankins D, Werther GA, Cameron FJ (2010) Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr Diabetes 11:235–243 (EK IIb)PubMedCrossRef

372.

Lind M, Svensson AM, Kosiborod M, Gudbjornsdottir S, Pivodic A, Wedel H, Dahlqvist S, Clements M, Rosengren A (2014) Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 371:1972–1982 (EK III)PubMedCrossRef

373.

Lindstrom C, Aman J, Norberg AL (2011) Parental burnout in relation to sociodemographic, psychosocial and personality factors as well as disease duration and glycaemic control in children with Type 1 diabetes mellitus. Acta Paediatr 100:1011–1017 (EK III)PubMedCrossRef

374.

Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679 (EK Ib)PubMedCrossRef

375.

Liu C, Wu D, Zheng X, Li P, Li L (2015) Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a metaanalysis. Diabetes Technol Ther 17:142–148 (EK 1b)PubMedCrossRef

376.

Lorini R, Klersy C, d’Annunzio G, Massa O, Minuto N, Iafusco D, Bellanne-Chantelot C, Frongia AP, Toni S, Meschi F, Cerutti F, Barbetti F (2009) Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. Diabetes Care 32:1864–1866PubMedPubMedCentralCrossRef

377.

Lorini R, Scotta MS, Cortona L, Avanzini MA, Vitali L, De Giacomo C, Scaramuzza A, Severi F (1996) Celiac disease and type I (insulindependent) diabetes mellitus in childhood: follow-up study. J Diabetes Complications 10:154–159 (EK III)PubMedCrossRef

378.

Ludvigsson J, Bolli GB (2001) Intensive insulin treatment in diabetic children. Diabetes Nutr Metab 14:292–304 (EK IIb)PubMed

379.

Ludvigsson J, Krisky D, Casas R, Battelino T, Castano L, Greening J, Kordonouri O, Otonkoski T, Pozzilli P, Robert JJ, Veeze HJ, Palmer J, Samuelsson U, Elding LH, Aman J, Kardell G, Neiderud HJ, Lundstrom G, Albinsson E, Carlsson A, Nordvall M, Fors H, Arvidsson CG, Edvardson S, Hanas R, Larsson K, Rathsman B, Forsgren H, Desaix H, Forsander G, Nilsson NO, Akesson CG, Keskinen P, Veijola R, Talvitie T, Raile K, Kapellen T, Burger W, Neu A, Engelsberger I, Heidtmann B, Bechtold S, Leslie D, Chiarelli F, Cicognani A, Chiumello G, Cerutti F, Zuccotti GV, Gomez GA, Rica I, Barrio R, Clemente M, Lopez Garcia MJ, Rodriguez M, Gonzalez I, Lopez JP, Oyarzabal M, Reeser HM, Nuboer R, Stouthart P, Bratina N, Bratanic N, de Kerdanet M, Weill J, Ser N, Barat P, Bertrand AM, Carel JC, Reynaud R, Coutant R, Baron S (2012) GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med 366:433–342PubMedCrossRef

380.

Ludwig-Seibold CU, Holder M, Rami B, Raile K, Heidtmann B, Holl RW (2012) Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria. Pediatr Diabetes 13:12–14PubMedCrossRef

381.

Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 15(Suppl 20):180–192 (EK IV)PubMedCrossRef

382.

Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW (2013) Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 310:1240–1247, EK Ib

383.

Maahs DM, Calhoun P, Buckingham BA, Chase HP, Hramiak I, Lum J, Cameron F, Bequette BW, Aye T, Paul T, Slover R, Wadwa RP, Wilson DM, Kollman C, Beck RW (2014) A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 37:1885–1891 (EK Ib)PubMedPubMedCentralCrossRef

384.

Maahs DM, Hermann JM, DuBose SN, Miller KM, Heidtmann B, Dimeglio LA, Rami-Merhar B, Beck RW, Schober E, Tamborlane WV, Kapellen TM, Holl RW (2014) Contrasting the clinical care and outcomes of 2622 children with type 1 diabetes less than 6 years of age in the United States T1 D Exchange and German/Austrian DPV registries. Diabetologia 57:1578–1585 (EK III)PubMedCrossRef

385.

Mahmud FH, Elbarbary NS, Fröhlich-Reiterer E et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 19(Suppl. 27):275–286PubMedPubMedCentralCrossRef

386.

Mann JI, De Leeuv I, Hermansen K, Karamanos B, Karlstrom B, Katsilambros N, Riccardi G, Rivellese AA, Rizkalla S, Slama G, Toeller M, Uusitupa M, Vessby B (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14:373–394PubMedCrossRef

387.

Mannucci E, Rotella F, Ricca V, Moretti S, Placidi GF, Rotella CM (2005) Eating disorders in patients with type 1 diabetes: a meta-analysis. J Endocrinol Invest 28:417–419 (EK Ia)PubMedCrossRef

388.

Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K (2008) High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 51:554–561 (IIb–III)PubMedCrossRef

389.

Markowitz JT, Butler DA, Volkening LK, Antisdel JE, Anderson BJ, Laffel LM (2010) Brief screening tool for disordered eating in diabetes: internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes. Diabetes Care 33:495–500 (EK III)PubMedCrossRef

390.

Martin D, Lange K, Sima A, Kownatka D, Skovlund S, Danne T, Robert JJ (2012) Recommendations for age-appropriate education of children and adolescents with diabetes and their parents in the European Union. Pediatr Diabetes 13(Suppl 16):20–28 (EK IV)PubMedCrossRef

391.

Marzelli MJ, Mazaika PK, Barnea-Goraly N, Hershey T, Tsalikian E, Tamborlane W, Mauras N, White NH, Buckingham B, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL (2014) Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 63:343–353 (EK III)PubMedCrossRef

392.

Mathiesen ER, Saurbrey N, Hommel E, Parving HH (1986) Prevalence of microalbuminuria in children with type 1 (insulindependent) diabetes mellitus. Diabetologia 29:640–643 (EK III)PubMedCrossRef

393.

Matthaei S, Bierwirth R, Fritsche A, Gallwitz B, Häring HU, Joost HG, Kellerer C, Kloos T, Kunt T, Nauck M, Schernthaner G, Siegel E, Thienel F (2008) Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2. Update der Evidenzbasierten Leitlinie der Deutschen Diabetes-Gesellschaft. http://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Leitlinien/Evidenzbasierte_Leitlinien/EBL_Dm_Typ2_Update_2008.pdf

394.

Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C (2012) A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to 〈 10 years. Diabetes Care 35:204–210 (EK Ib)PubMedPubMedCentralCrossRef

395.

Mayer-Davis EJ, Kahkoska AR, Jefferies C et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 19(Suppl. 27):7–19. https://doi.org/10.1111/pedi.12773CrossRefPubMedPubMedCentral

396.

McBroom LA, Enriquez M (2009) Review of family-centered interventions to enhance the health outcomes of children with type 1 diabetes. Diabetes Educ 35:428–438 (EK Ia)PubMedCrossRef

397.

McDonald TJ, Ellard S (2013) Maturity onset diabetes of the young: identification and diagnosis. Ann Clin Biochem 50:403–415 (EK III)PubMedCrossRef

398.

McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, Hofer S, Fritsch M, Schober E, Svensson J, Almdal T, Young R, Warner JT, Delemer B, Souchon PF, Holl RW, Karges W, Kieninger DM, Tigas S, Bargiota A, Sampanis C, Cherubini V, Gesuita R, Strele I, Pildava S, Coppell KJ, Magee G, Cooper JG, Dinneen SF, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Veeze H, Aanstoot HJ, Khalangot M, Tamborlane WV, Miller KM (2015) Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 32:1036–1050 (EK IIb)PubMedCrossRef

399.

Meltzer LJ, Johnson SB, Prine JM, Banks RA, Desrosiers PM, Silverstein JH (2001) Disordered eating, body mass, and glycemic control in adolescents with type 1 diabetes. Diabetes Care 24:678–682 (EK III)PubMedCrossRef

400.

Mensink RP, Zock PL, Kester AD, Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77:1146–1155 (EK Ia)PubMedCrossRef

401.

Milla CE, Warwick WJ, Moran A (2000) Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 162:891–895 (EK III)PubMedCrossRef

402.

Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH, Hirsch IB (2013) Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1 D exchange clinic registry participants. Diabetes Care 36:2009–2014 (EK III)PubMedPubMedCentralCrossRef

403.

Miller-Johnson S, Emery RE, Marvin RS, Clarke W, Lovinger R, Martin M (1994) Parent-child relationships and the management of insulin-dependent diabetes mellitus. J Consult Clin Psychol 62:603–610 (EK III)PubMedCrossRef

404.

Misso ML, Egberts KJ, Page M, O’Connor D, Shaw J (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. CD005103, Ia

405.

Mlynarski W, Tarasov AI, Gach A, Girard CA, Pietrzak I, Zubcevic L, Kusmierek J, Klupa T, Malecki MT, Ashcroft FM (2007) Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat Clin Pract Neurol 3:640–645 (EK III)PubMedCrossRef

406.

Mohn A, Di MS, Di LR, Tumini S, Chiarelli F (2002) The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus. Diabet Med 19:70–73 (EK IIa)PubMedCrossRef

407.

Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M, Pozzilli P (2001) Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes. Diabetes Metab Res Rev 17:51–54 (EK III)PubMedCrossRef

408.

Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB (1992) Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes 41:1035–1041 (EK IIb)PubMedCrossRef

409.

Morris LR, Murphy MB, Kitabchi AE (1986) Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med 105:836–840PubMedCrossRef

410.

Mortensen HB, Hougaard P, Ibsen KK, Parving HH (1994) Relationship between blood pressure and urinary albumin excretion rate in young Danish type 1 diabetic patients: comparison to non-diabetic children. Danish Study Group of Diabetes in Childhood. Diabet Med 11:155–161 (EK IIa)PubMedCrossRef

411.

Mortensen HB, Lindholm A, Olsen BS, Hylleberg B (2000) Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes. Eur J Pediatr 159:483–488 (EK Ib)PubMedCrossRef

412.

Mortensen HB, Robertson KJ, Aanstoot HJ, Danne T, Holl RW, Hougaard P, Atchison JA, Chiarelli F, Daneman D, Dinesen B, Dorchy H, Garandeau P, Greene S, Hoey H, Kaprio EA, Kocova M, Martul P, Matsuura N, Schoenle EJ, Sovik O, Swift PG, Tsou RM, Vanelli M, Aman J (1998) Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidore Study Group on Childhood Diabetes. Diabet Med 15:752–759 (EK III)PubMedCrossRef

413.

Muir AB, Quisling RG, Yang MC, Rosenbloom AL (2004) Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care 27:1541–1546 (EK IIb–III)PubMedCrossRef

414.

Mulvaney SA, Rothman RL, Osborn CY, Lybarger C, Dietrich MS, Wallston KA (2011) Self-management problem solving for adolescents with type 1 diabetes: intervention processes associated with an Internet program. Patient Educ Couns 85:140–142 (EK IIb)PubMedCrossRef

415.

Mulvaney SA, Rothman RL, Wallston KA, Lybarger C, Dietrich MS (2010) An internet-based program to improve self-management in adolescents with type 1 diabetes. Diabetes Care 33:602–604 (EK IIb)PubMedCrossRef

416.

Murphy HR, Rayman G, Skinner TC (2006) Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med 23:935–943 (EK Ia)PubMedCrossRef

417.

Murphy HR, Rayman G, Skinner TC (2006) Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med 23:935–943 (EK Ib)PubMedCrossRef

418.

Murphy R, Ellard S, Hattersley AT (2008) Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 4:200–213 (EK IV)PubMedCrossRef

419.

Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bayless M, Silvers N, Harth J, White N (2008) Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diabetes Care 31:1933–1938 (EK Ib)PubMedPubMedCentralCrossRef

420.

Naar-King S, Idalski A, Ellis D, Frey M, Templin T, Cunningham PB, Cakan N (2006) Gender differences in adherence and metabolic control in urban youth with poorly controlled type 1 diabetes: the mediating role of mental health symptoms. J Pediatr Psychol 31:793–802 (EK III)PubMedCrossRef

421.

Nadeau KJ, Klingensmith G, Zeitler P (2005) Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 41:94–98 (EK IIb–III)PubMedCrossRef

422.

Naguib JM, Kulinskaya E, Lomax CL, Garralda ME (2009) Neurocognitive performance in children with type 1 diabetes—a meta-analysis. J Pediatr Psychol 34:271–282 (EK Ib)PubMedCrossRef

423.

Nahata L (2006) Insulin therapy in pediatric patients with type I diabetes: continuous subcutaneous insulin infusion versus multiple daily injections. Clin Pediatr (Phila) 45:503–508 (EK Ia)CrossRef

424.

Nakhla M, Daneman D, Frank M, Guttmann A (2008) Translating transition: a critical review of the diabetes literature. J Pediatr Endocrinol Metab 21:507–516 (EK III)PubMedCrossRef

425.

Nallasamy K, Jayashree M, Singhi S, Bansal A (2014) Low-dose vs standard-dose insulin in pediatric diabetic ketoacidosis: a randomized clinical trial. JAMA Pediatr 168:999–1005 (EK Ib)PubMedCrossRef

426.

Nansel TR, Iannotti RJ, Liu A (2012) Clinic-integrated behavioral intervention for families of youth with type 1 diabetes: randomized clinical trial. Pediatrics 129:e866–e873 (EK Ib)PubMedPubMedCentralCrossRef

427.

Nansel TR, Iannotti RJ, Simons-Morton BG, Cox C, Plotnick LP, Clark LM, Zeitzoff L (2007) Diabetes personal trainer outcomes: short-term and 1‑year outcomes of a diabetes personal trainer intervention among youth with type 1 diabetes. Diabetes Care 30:2471–2477 (EK IIb)PubMedCrossRef

428.

Nansel TR, Iannotti RJ, Simons-Morton BG, Plotnick LP, Clark LM, Zeitzoff L (2009) Long-term maintenance of treatment outcomes: diabetes personal trainer intervention for youth with type 1 diabetes. Diabetes Care 32:807–809 (EK IIb)PubMedPubMedCentralCrossRef

429.

Nardi L, Zucchini S, D’Alberton F, Salardi S, Maltoni G, Bisacchi N, Elleri D, Cicognani A (2008) Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnaires. Pediatr Diabetes 9:496–503 (EK III)PubMedCrossRef

430.

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653, EK Ib

431.

Neu A, Ehehalt S, Bendas A, Rothe U, Kiess W, Holl RW, Stahl-Pehe A, Rosenbauer J (2013) Incidence of childhood type 1 diabetes in Germany: a nationwide survey over a period of ten years. Pediatr Diabetes 14:119

432.

Neu A, Ehehalt S, Feldhahn LM, Kehrer M, Willasch AM, Hub R, Ranke MB (2008) Diabeteshäufigkeit bei Kindern und Jugendlichen in Deutschland – 20 Jahre Diabetes-Inzidenzregister Baden-Württemberg. Diabetol Stoffwechs. https://doi.org/10.1055/s-2008-1076985CrossRef

433.

Neu A, Ehehalt S, Willasch A, Kehrer M, Hub R, Ranke MB (2001) Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age. Diabetes Care 24:785–786PubMedCrossRef

434.

Neu A, Feldhahn L, Ehehalt S et al (2018) No change in type 2 diabetes prevalence in children and adolescents over 10 years: Update of a population-based surveyin South Germany. Pediatr Diabetes 19:637–639. https://doi.org/10.1111/pedi.12622CrossRefPubMed

435.

Neu A, Feldhahn L, Ehehalt S, Hub R, Ranke MB (2005) Prevalence of type 2 diabetes and MODY in children and adolescents. A state-wide study in Baden-Wuerttemberg (Germany). Pediatr Diabetes 6:27–28 (EK III)

436.

Neu A, Hofer SE, Karges B, Oeverink R, Rosenbauer J, Holl RW (2009) Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14 664 patients from 106 institutions. Diabetes Care 32:1647–1648 (EK IIb)PubMedPubMedCentralCrossRef

437.

Neu A, Lange K, Lösch-Binder M, Ziegler R: Diabetes – na und? DVD mit drei Informationsfilmen für Lehrer/innen von Kindern mit Diabetes zum Einsatz im Unterricht, = Arbeitsgemeinschaft pädiatrische Diabetologie (AGPD), (2011)

438.

Neu A, Losch-Binder M, Ehehalt S, Schweizer R, Hub R, Serra E (2010) Follow-up of adolescents with diabetes after transition from paediatric to adult care: results of a 10-year prospective study. Exp Clin Endocrinol Diabetes 118:353–355 (EK III)PubMedCrossRef

439.

Neu A, Willasch A, Ehehalt S, Hub R, Ranke MB (2003) Ketoacidosis at onset of type 1 diabetes mellitus in children–frequency and clinical presentation. Pediatr Diabetes 4:77–81 (EK III)PubMedCrossRef

440.

Neuhauser H, Schienkiewitz A, Schaffrath RA, Dortschy R, Kurth BM, Robert Koch Institut (2013) Referenzperzentile für anthropometrische Maßzahlen und Blutdruck aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS) Bd. 2. RKI, Berlin

441.

Neuhauser HK, Thamm M, Ellert U, Hense HW, Rosario AS (2011) Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics 127:e978–e988PubMedCrossRef

442.

Nichols PJ, Norris SL (2002) A systematic literature review of the effectiveness of diabetes education of school personnel. Diabetes Educ 28:405–414 (EK III)PubMedCrossRef

443.

Nieuwesteeg A, Pouwer F, van der Kamp R, van Bakel H, Aanstoot H‑J, Hartman E (2012) Quality of life of children with type 1 diabetes: a systematic review. Curr Diabetes Rev 8:434–443 (EK III)PubMedCrossRef

444.

Nimri R, Muller I, Atlas E, Miller S, Fogel A, Bratina N, Kordonouri O, Battelino T, Danne T, Phillip M (2014) MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 37:3025–3032 (EK Ib)PubMedCrossRef

445.

Nimri R, Weintrob N, Benzaquen H, Ofan R, Fayman G, Phillip M (2006) Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Pediatrics 117:2126–2131 (EK IIb–III)PubMedCrossRef

446.

Nordfeldt S, Ludvigsson J (1999) Adverse events in intensively treated children and adolescents with type 1 diabetes. Acta Paediatr 88:1184–1193 (EK IIb)PubMedCrossRef

447.

Nordfeldt S, Ludvigsson J (2005) Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 18:83–91 (EK III)PubMedCrossRef

448.

Nordwall M, Hyllienmark L, Ludvigsson J (2006) Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment. J Pediatr Endocrinol Metab 19:45–54 (EK III)PubMedCrossRef

449.

Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M (2003) Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290:1713–1720 (EK III)PubMedCrossRef

450.

Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D (1998) Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 21:379–384 (EK III)PubMedCrossRef

451.

Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA (2005) Psychiatric morbidity and health outcome in Type 1 diabetes—perspectives from a prospective longitudinal study. Diabet Med 22:152–157 (EK III)PubMedCrossRef

452.

Northam EA, Todd S, Cameron FJ (2006) Interventions to promote optimal health outcomes in children with Type 1 diabetes—are they effective? Diabet Med 23:113–121 (EK Ia–III)PubMedCrossRef

453.

Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M (2001) Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 90:515–519 (EK III)PubMedCrossRef

454.

O’Hayon BE, Cummings EA, Daneman D, Ossip MG, Lawson ML, Sochett EB (2000) Does dietary protein intake correlate with markers suggestive of early diabetic nephropathy in children and adolescents with Type 1 diabetes mellitus? Diabet Med 17:708–712 (EK III)PubMedCrossRef

455.

O’Riordan SM, Robinson PD, Donaghue KC, Moran A (2008) Management of cystic fibrosis-related diabetes. Pediatr Diabetes 9:338–344PubMedCrossRef

456.

Okuda Y, Adrogue HJ, Field JB, Nohara H, Yamashita K (1996) Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab 81:314–320PubMed

457.

Olmsted MP, Daneman D, Rydall AC, Lawson ML, Rodin G (2002) The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. Int J Eat Disord 32:230–239 (EK Ib)PubMedCrossRef

458.

Overby NC, Margeirsdottir HD, Brunborg C, Andersen LF, hl-Jorgensen K (2007) The influence of dietary intake and meal pattern on blood glucose control in children and adolescents using intensive insulin treatment. Diabetologia 50:2044–2051, EK IIb

459.

Overstreet S, Goins J, Chen RS, Holmes CS, Greer T, Dunlap WP, Frentz J (1995) Family environment and the interrelation of family structure, child behavior, and metabolic control for children with diabetes. J Pediatr Psychol 20:435–447 (EK IIa)PubMedCrossRef

460.

Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H (2008) Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes : (EK Ia)

461.

Pankowska E, Szypowska A, Lipka M, Skorka A (2007) Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion. Acta Paediatr 96:881–884 (EK IIb–III)PubMedCrossRef

462.

Pattison HM, Moledina S, Barrett TG (2006) The relationship between parental perceptions of diabetes and glycaemic control. Arch Dis Child 91:487–490 (EK III)PubMedCrossRef

463.

Pavlovic MD, Milenkovic T, Dinic M, Misovic M, Dakovic D, Todorovic S, Dakovic Z, Zecevi RD, Doder R (2007) The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care 30:1964–1967 (EK III)PubMedCrossRef

464.

Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Sovik O, Polak M, Hattersley AT (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467–477 (EK III)PubMedCrossRef

465.

Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT (2000) Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 17:543–545 (EK III)PubMedCrossRef

466.

Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Sadler M, White NH, Hershey T (2008) Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 9:87–95 (EK III)PubMedCrossRef

467.

Persson S, Dahlquist G, Gerdtham UG, Steen CK (2013) Impact of childhood-onset type 1 diabetes on schooling: a populationbased register study. Diabetologia 56:1254–1262 (EK IIb)PubMedCrossRef

468.

Peterson DB, Lambert J, Gerring S, Darling P, Carter RD, Jelfs R, Mann JI (1986) Sucrose in the diet of diabetic patients—just another carbohydrate? Diabetologia 29:216–220 (EK Ib)PubMedCrossRef

469.

Peyrot M, Rubin RR (2007) Behavioral and psychosocial interventions in diabetes: a conceptual review. Diabetes Care 30:2433–2440 (EK Ib)PubMedCrossRef

470.

Peyrot M, Rubin RR (2013) Treatment satisfaction in the sensoraugmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabet Med 30:464–467 (EK Ib)PubMedCrossRef

471.

Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T (2013) Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 368:824–833 (EK Ib)PubMedCrossRef

472.

Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F (2007) Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30:1653–1662PubMedCrossRef

473.

Philotheou A, Arslanian S, Blatniczky L, Peterkova V, Souhami E, Danne T (2011) Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes. Diabetes Technol Ther 13:327–334PubMedPubMedCentralCrossRef

474.

Pihoker C, Forsander G, Fantahun B, Virmani A, Luo X, Hallman M, Wolfsdorf J, Maahs DM (2014) ISPAD Clinical Practice Consensus Guidelines 2014. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes 15(Suppl 20):86–101 (EK IV)PubMedCrossRef

475.

Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, Pieber TR (2005) Systematic review and meta-analysis of shortacting insulin analogues in patients with diabetes mellitus. Arch Intern Med 165:1337–1344 (EK Ia)PubMedCrossRef

476.

Plener PL, Molz E, Berger G, Schober E, Monkemoller K, Denzer C, Goldbeck L, Holl RW (2015) Depression, metabolic control, and antidepressant medication in young patients with type 1 diabetes. Pediatr Diabetes 16:58–66 (EK IIb)PubMedCrossRef

477.

Polak M, Dechaume A, Cave H, Nimri R, Crosnier H, Sulmont V, de Kerdanet M, Scharfmann R, Lebenthal Y, Froguel P, Vaxillaire M (2008) Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes 57:1115–1119 (EK III)PubMedCrossRef

478.

Povlsen L, Olsen B, Ladelund S (2005) Diabetes in children and adolescents from ethnic minorities: barriers to education, treatment and good metabolic control. J Adv Nurs 50:576–582 (EK III)PubMedCrossRef

479.

Powers SW, Byars KC, Mitchell MJ, Patton SR, Standiford DA, Dolan LM (2002) Parent report of mealtime behavior and parenting stress in young children with type 1 diabetes and in healthy control subjects. Diabetes Care 25:313–318 (EK III)PubMedCrossRef

480.

Puttha R, Cooke D, Subbarayan A, Odeka E, Ariyawansa I, Bone M, Doughty I, Patel L, Amin R (2010) Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes—an observational study. Pediatr Diabetes 11:12–17 (EK III)PubMedCrossRef

481.

Radetti G, Paganini C, Gentili L, Bernasconi S, Betterle C, Borkenstein M, Cvijovic K, Kadrnka-Lovrencic M, Krzisnik C, Battelino T (1995) Frequency of Hashimoto’s thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol 32:121–124 (EK III)PubMedCrossRef

482.

Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, Holl RW (2007) Diabetic nephropathy in 27.805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30:2523–2528, EK IIb–III

483.

Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Muller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Gruters A (2009) Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab 94:2658–2664 (EK IV)PubMedCrossRef

484.

Raile K, O’Connell M, Galler A, Werther G, Kuhnen P, Krude H, Blankenstein O (2011) Diabetes caused by insulin gene (INS) deletion: clinical characteristics of homozygous and heterozygous individuals. Eur J Endocrinol 165:255–260PubMedCrossRef

485.

Raile K, Schober E, Konrad K, Thon A, Grulich-Henn J, Meissner T, Wolfle J, Scheuing N, Holl RW (2015) Treatment of young patients with HNF1A mutations (HNF1A-MODY). Diabet Med 32:526–530PubMedCrossRef

486.

Rattay P, von der Lampert LET (2014) Gesundheit von Kindern und Jugendlichen in Eineltern‑, Stief- und Kernfamilien. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:860–868 (EK IIb)PubMedCrossRef

487.

Reid GJ, Dubow EF, Carey TC, Dura JR (1994) Contribution of coping to medical adjustment and treatment responsibility among children and adolescents with diabetes. J Dev Behav Pediatr 15:327–335 (EK III)PubMedCrossRef

488.

Reinehr T, Schober E, Roth CL, Wiegand S, Holl R (2008) Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res 69:107–113 (EK III)PubMed

489.

Reinehr T, Temmesfeld M, Kersting M, de Sousa G, Toschke AM (2007) Four-year follow-up of children and adolescents participating in an obesity intervention program. Int J Obes 31:1074–1077 (EK III)CrossRef

490.

Renders CM, Valk GD, Griffin SJ, Wagner EH, Van Eijk JT, Assendelft WJ (2001) Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care 24:1821–1833 (EK Ia)PubMedCrossRef

491.

Rewers A, Klingensmith G, Davis C, Petitti DB, Pihoker C, Rodriguez B, Schwartz ID, Imperatore G, Williams D, Dolan LM, Dabelea D (2008) Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 121:e1258–e1266 (EK III)PubMedCrossRef

492.

Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2007) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 8:408–418PubMedCrossRef

493.

Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2007) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 8:408–418 (EK IV)PubMedCrossRef

494.

Reynolds KA, Helgeson VS (2011) Children with diabetes compared to peers: depressed? Distressed? A meta-analytic review. Ann Behav Med 42:29–41 (EK Ib)PubMedCrossRef

495.

Riccardi G, Rivellese A, Pacioni D, Genovese S, Mastranzo P, Mancini M (1984) Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 26:116–421 (EK Ib)PubMedCrossRef

496.

Richter B, Neises G (2005) ‘Human’ insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev CD003 816: (EK Ia)

497.

Riddell MC, Iscoe KE (2006) Physical activity, sport, and pediatric diabetes. Pediatr Diabetes 7:60–70 (EK IV)PubMedCrossRef

498.

Riley MD, Dwyer T (1998) Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus. Am J Clin Nutr 67:50–57 (EK III)PubMedCrossRef

499.

Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, Tubiana-Rufi N, Sulmont V, Catargi B, Lukas C, Radermecker RP, Thivolet C, Moreau F, Benhamou PY, Guerci B, Leguerrier AM, Millot L, Sachon C, Charpentier G, Hanaire H (2012) Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care 35:965–971 (EK Ib)PubMedPubMedCentralCrossRef

500.

Rivellese A, Riccardi G, Giacco A, Pacioni D, Genovese S, Mattioli PL, Mancini M (1980) Effect of dietary fibre on glucose control and serum lipoproteins in diabetic patients. Lancet 2:447–450 (EK Ib)PubMedCrossRef

501.

Roberts MD, Slover RH, Chase HP (2001) Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes 2:109–114 (EK III)PubMedCrossRef

502.

Robertson K, Riddell MC, Guinhouya BC, Adolfsson P, Hanas R (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Exercise in children and adolescents with diabetes. Pediatr Diabetes 15(Suppl 20):203–223 (EK IV)PubMedCrossRef

503.

Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J (2007) Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabet Med 24:27–34 (EK Ib)PubMedCrossRef

504.

Rohrer T, Stierkorb E, Grabert M, Holterhus PM, Kapellen T, Knerr I, Mix M, Holl RW (2008) Delayed menarche in young German women with type 1 diabetes mellitus: recent results from the DPV diabetes documentation and quality management system. Eur J Pediatr 167:793–799PubMedCrossRef

505.

Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M (2001) Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 90:860–867 (EK III)PubMed

506.

Ronkainen MS, Hamalainen AM, Koskela P, Akerblom HK, Knip M (2001) Pregnancy induces nonimmunoglobulin insulinbinding activity in both maternal and cord blood serum. Clin Exp Immunol 124:190–196 (EK Ib)PubMedPubMedCentralCrossRef

507.

Rosenbauer J, Dost A, Karges B, Hungele A, Stahl A, Bachle C, Gerstl EM, Kastendieck C, Hofer SE, Holl RW (2012) Improved metabolic control in children and adolescents with type 1 diabetes: a trend analysis using prospective multicenter data from Germany and Austria. Diabetes Care 35:80–86 (EK III)PubMedCrossRef

508.

Rosenbauer J, Herzig P, Giani G (2003) Familial risk Type 1 diabetes mellitus in preschool age. Diabetologia 46:A118 (EK IIa)

509.

Rosenbauer J, Icks A, du Prel JB, Giani G (2003) Populationsbasierte Daten zur Inzidenz des Typ‑2-Diabetes mellitus bei Kindern und Jugendlichen in Deutschland. Monatsschr Kinderheilkd 151:71, EK III

510.

Rosenbauer J, Icks A, Giani G (2002a) Clinical characteristics and predictors of severe ketoacidosis at onset of type 1 diabetes mellitus in children in a North Rhine-Westphalian region, Germany. J Pediatr Endocrinol Metab 15:1137–1145 (EK IIb)PubMedCrossRef

511.

Rosenbauer J, Icks A, Giani G (2002b) Incidence and prevalence of childhood type 1 diabetes mellitus in Germany—model-based national estimates. J Pediatr Endocrinol Metab 15:1497–1504 (EK IIb)PubMedCrossRef

512.

Rosenbauer J, Icks A, Grabert M, Holl RW, Giani G (2002) Hohe Prävalenz des Typ-1-Diabetes mellitus im Kindes- und Jugendalter in Deutschland (Abstract). Kinder Jugendmed 2:A84 (EK III)

513.

Rosenbauer J, Rothe U, Bendas A, Kiess W, Baechle C, Holl RW, Ehehalt S, Neu A, in cooperation with the DIARY Group Baden-Wuerttemberg tCDRiStGPSUEatD-SI. (2013) National prevalence estimates of childhood type 1 diabetes in Germany. Pediatr Diabetes 14:119 (EK III)

514.

Rosenbloom AL, Schatz DA, Krischer JP, Skyler JS, Becker DJ, Laporte RE, Libman I, Pietropaolo M, Dosch HM, Finberg L, Muir A, Tamborlane WV, Grey M, Silverstein JH, Malone JI (2000) Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab 85:494–522 (EK IV)PubMed

515.

Rubio-Cabezas O, Klupa T, Malecki MT (2011) Permanent neonatal diabetes mellitus—the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Invest 41:323–333PubMedCrossRef

516.

Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK (1997) Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics 100:968–972 (EK IIa)PubMedCrossRef

517.

Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3–10 (EK Ib)PubMedCrossRef

518.

Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, Abuelo D, Phornphutkul C, Molnes J, Bell GI, Gloyn AL, Hattersley AT, Molven A, Sovik O, Njolstad PR (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713–2718 (EK III)PubMedCrossRef

519.

Saßmann H, Albrecht C, Busse-Widmann P, Hevelke LK, Kranz J, Markowitz JT, Marshall LF, Meurs S, de Soye IH, Lange K (2015) Psychometric properties of the German version of the Diabetes Eating Problem Survey-Revised: additional benefit of disease-specific screening in adolescents with Type 1 diabetes. Diabet Med : (EK IIb)

520.

Sassmann H, Danne T, Landgraf R, Lange K (2007) Jugendliche und junge Erwachsene mit Diabetes: Lebensqualität, Stoffwechseleinstellung und Zufriedenheit mit der Langzeitbetreuung von Teilnehmern des CAMP‑D. Diabetes Stoffwechs 2:69 (EK III)

521.

Sassmann H, de Hair M, Danne T, Lange K (2012) Reducing stress and supporting positive relations in families of young children with type 1 diabetes: a randomized controlled study for evaluating the effects of the DELFIN parenting program. BMC Pediatr 12:152 (EK Ib)PubMedPubMedCentralCrossRef

522.

Saßmann H, Lange K (2013) Psychische Störungen bei Kindern und Jugendlichen mit Diabetes. In: Petrak F, Herpertz S (Hrsg) Handbuch der Psychodiabetologie. Springer, Berlin (EK IV)

523.

Schatz DA, Bingley PJ (2001) Update on major trials for the prevention of type 1 diabetes mellitus: the American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT). J Pediatr Endocrinol Metab 14(Suppl 1):619–622 (EK Ib)PubMed

524.

Scherbaum W (1998) Verlautbarung der Deutschen Diabetes-Gesellschaft zur Versorgung von Kindern und Jugendlichen. Diabet Inform 20:23 (EK IV)

525.

Scheuing N, Bartus B, Berger G, Haberland H, Icks A, Knauth B, Nellen-Hellmuth N, Rosenbauer J, Teufel M, Holl RW (2014) Clinical characteristics and outcome of 467 patients with a clinically recognized eating disorder identified among 52 215 patients with type 1 diabetes: a multicenter german/austrian study. Diabetes Care 37:1581–1589 (EK IIb)PubMedCrossRef

526.

Schiaffini R, Patera PI, Bizzarri C, Ciampalini P, Cappa M (2007) Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin. J Endocrinol Invest 30:572–577 (EK Ib)PubMedCrossRef

527.

Schlesinger DM, Holsclaw DS, Fyfe B (1997) Generalized Atherosclerosis in an Adult with CF and Diabetes Mellitus. Eleventh Annual North American Cystic Fibrosis Conference, S 365 (EK III)

528.

Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M (2014) Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. J Cyst Fibros 13:80–85PubMedCrossRef

529.

Schober E, Holl RW, Grabert M, Thon A, Rami B, Kapellen T, Seewi O, Reinehr T (2005) Diabetes mellitus type 2 in childhood and adolescence in Germany and parts of Austria. Eur J Pediatr 164:705–707 (EK III)PubMedCrossRef

530.

Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW (2009) Phenotypical aspects of Maturity-onset diabetes of the young (MODY diabetes) in comparison to Type 2 diabetes mellitus (T2DM) in children and adolescents. Experience from a large multicenter data base. Diabet Med 26:466–473PubMedCrossRef

531.

Schoenle EJ, Schoenle D, Molinari L, Largo RH (2002) Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 45:108–114 (EK III)PubMedCrossRef

532.

Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22:495–502 (EK III)PubMedCrossRef

533.

Schultz CJ, Neil HA, Dalton RN, Konopelska BT, Dunger DB (2001) Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Diabetes Care 24:555–560, EK III

534.

Schwab KO, Doerfer J, Marg W, Schober E, Holl RW (2010) Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors. Pediatr Diabetes 11:357–363PubMedCrossRef

535.

Schwartz DD, Cline VD, Axelrad ME, Anderson BJ (2011) Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes. Diabetes Care 34:326–331 (EK III)PubMedPubMedCentralCrossRef

536.

Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A (2007) Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30:1056–1061 (EK III)PubMedCrossRef

537.

Scott A, Whitcombe S, Bouchier D, Dunn P (2004) Diabetes in children and young adults in Waikato Province, New Zealand: outcomes of care. N Z Med J 117:U1219 (EK III)PubMed

538.

Scottish Intercollegiate Guidelines Network (SIGN) (2014) SIGN 50: A guideline developer’s handbook. Quick reference guide

539.

Scottish Study Group for the Care of the Young Diabetic. (2001) Factors influencing glycemic control in young people with type 1 diabetes in Scotland: a population-based study (DIABAUD2). Diabetes Care 24:239–244 (EK IIa)CrossRef

540.

Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP (2007) Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 9:421–428 (EK IIb–III)PubMedCrossRef

541.

Shah RP, Spruyt K, Kragie BC, Greeley SA, Msall ME (2012) Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas. Diabetes Care 35:2086–2088PubMedPubMedCentralCrossRef

542.

Shepherd M, Hattersley AT (2004) “I don’t feel like a diabetic any more”: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clin Med 4:144–147CrossRef

543.

Sherr JL, Tauschmann M, Battelino T et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. Pediatr Diabetes 19(Suppl. 27):302–325PubMedCrossRef

544.

Shichiri M, Kishikawa H, Ohkubo Y, Wake N (2000) Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23(Suppl 2):B21–B29PubMed

545.

Shimazaki T, Kadowaki T, Ohyama Y, Ohe K, Kubota K (2007) Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 149:196–204 (EK II)PubMedCrossRef

546.

Shorer M, David R, Schoenberg-Taz M, Levavi-Lavi I, Phillip M, Meyerovitch J (2011) Role of parenting style in achieving metabolic control in adolescents with type 1 diabetes. Diabetes Care 34:1735–1737 (EK III)PubMedPubMedCentralCrossRef

547.

Sideravicite S, Gailiniene A, Visagurskiene K, Vizbaraite D (2006) The effect of long-term swimming program on glycemia control in 14–19-year aged healthy girls and girls with type 1 diabetes mellitus. Medicina (Kaunas) 42:513–518 (EK IIb)

548.

Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR (2006) Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev CD003287: (EK Ia)

549.

Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186–212 (EK IV)PubMedCrossRef

550.

Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186–212PubMedCrossRef

551.

Simpson D, McCormack PL, Keating GM, Lyseng-Williamson KA (2007) Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs 67:407–434PubMedCrossRef

552.

Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J (2008) Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. Pediatr Diabetes 9:472–479 (EK1b)PubMedCrossRef

553.

Slama G, Haardt MJ, Jean-Joseph P, Costagliola D, Goicolea I, Bornet F, Elgrably F, Tchobroutsky G (1984) Sucrose taken during mixed meal has no additional hyperglycaemic action over isocaloric amounts of starch in well-controlled diabetics. Lancet 2:122–125 (EK Ib)PubMedCrossRef

554.

Slingerland AS, Hurkx W, Noordam K, Flanagan SE, Jukema JW, Meiners LC, Bruining GJ, Hattersley AT, Hadders-Algra M (2008) Sulphonylurea therapy improves cognition in a patient with the V59 M KCNJ11 mutation. Diabet Med 25:277–281 (EK III)PubMedCrossRef

555.

Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV (2012) Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 13:6–11 (EK Ib)PubMedCrossRef

556.

Smart CE, Annan F, Bruno LP, Higgins LA, Acerini CL (2014) ISPAD—Clinical Practice Consensus Guidelines 2014. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes 15(Suppl 20):135–153 (EK IV)PubMedCrossRef

557.

Smith-Palmer J, Brandle M, Trevisan R, Orsini FM, Liabat S, Valentine W (2014) Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res Clin Pract 105:273–284PubMedCrossRef

558.

Sochett EB, Poon I, Balfe W, Daneman D (1998) Ambulatory blood pressure monitoring in insulin-dependent diabetes mellitus adolescents with and without microalbuminuria. J Diabetes Complications 12:18–23 (EK IIa)PubMedCrossRef

559.

Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S (2003) A doubleblind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens 16:795–800 (EK Ib)PubMedCrossRef

560.

Sood ED, Pendley JS, Delamater AM, Rohan JM, Pulgaron ER, Drotar D (2012) Mother-father informant discrepancies regarding diabetes management: associations with diabetes-specific family conflict and glycemic control. Health Psychol 31:571–579, EK III

561.

Stachow R, Schiel R, Koch S, Fiedler S, Hermann T, Holl RW (2013a) Effekte der stationären Rehabilitation von Kindern und Jugendlichen mit Diabetes mellitus Typ‑1. Monatsschr Kinderheilkd 161:727–734 (EK III)CrossRef

562.

Stachow R, Schiel R, Koch S, Fiedler S, Hermann T, Holl RW (2013b) Langfristige Effekte der Rehabilitation für Kinder und Jugendliche mit Diabetes mellitus Typ 1. Diabetol Stoffwechs 8:FV17 (EK III)CrossRef

563.

Stachow R, Schultz A, Kurzinsky U, Petermann F, Hampel P (2001) Anti-Streß-Training für Kinder und Jugendliche mit Diabetes während der stationären Rehabilitation. Kindh Entwickl 10:226–239 (EK III)CrossRef

564.

Stachow R, Wolf J, Kromeyer-Hauschild K, Dost A, Wabitsch M, Grabert M, Holl RW (2003) Übergewicht und Adipositas bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1. Prävalenz und Einflussfaktoren. Monatsschr Kinderheilkd 149:209–216 (EK III)

565.

Stahl A, Strassburger K, Lange K, Bachle C, Holl RW, Giani G, Rosenbauer J (2012) Health-related quality of life among German youths with early-onset and long-duration type 1 diabetes. Diabetes Care 35:1736–1742 (EK IIB)PubMedPubMedCentralCrossRef

566.

Stahl-Pehe A, Strassburger K, Castillo K, Bachle C, Holl RW, Lange K, Rosenbauer J (2014) Quality of life in intensively treated youths with early-onset type 1 diabetes: a population-based survey. Pediatr Diabetes 15:436–443 (EK IIB)PubMedCrossRef

567.

Stanger C, Ryan SR, Delhey LM, Thrailkill K, Li Z, Li Z, Budney AJ (2013) A multicomponent motivational intervention to improve adherence among adolescents with poorly controlled type 1 diabetes: a pilot study. J Pediatr Psychol 38:629–637 (EK III)PubMedPubMedCentralCrossRef

568.

Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, Ciljakova M, Hlava P, Michalek J, Flanagan SE, Pearson E, Hattersley AT, Ellard S, Klimes I (2007) Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276–1282PubMedCrossRef

569.

Stoy J, Edghill EL, Flanagan SE, Ye H, Paz VP, Pluzhnikov A, Below JE, Hayes MG, Cox NJ, Lipkind GM, Lipton RB, Greeley SA, Patch AM, Ellard S, Steiner DF, Hattersley AT, Philipson LH, Bell GI (2007) Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 104:15 040–15 044 (EK III)CrossRef

570.

Stride A, Vaxillaire M, Tuomi T, Barbetti F, Njolstad PR, Hansen T, Costa A, Conget I, Pedersen O, Sovik O, Lorini R, Groop L, Froguel P, Hattersley AT (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427–435 (EK IIb)PubMedCrossRef

571.

Sullivan-Bolyai S, Bova C, Lee M, Gruppuso PA (2011) Mentoring fathers of children newly diagnosed with T1DM. MCN Am J Matern Child Nurs 36:224–231PubMedCrossRef

572.

Sullivan-Bolyai S, Deatrick J, Gruppuso P, Tamborlane W, Grey M (2003) Constant vigilance: mothers’ work parenting young children with type 1 diabetes. J Pediatr Nurs 18:21–29 (EK III)PubMedCrossRef

573.

Summers LK, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, Moore NR, Frayn KN (2002) Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45:369–377 (EK Ib)PubMedCrossRef

574.

Sundelin J, Forsander G, Mattson SE (1996) Family-oriented support at the onset of diabetes mellitus: a comparison of two group conditions during 2 years following diagnosis. Acta Paediatr 85:49–55 (EK III)PubMedCrossRef

575.

Sundelin J, Forsander G, Mattson SE (1996) Family-oriented support at the onset of diabetes mellitus: a comparison of two group conditions during 2 years following diagnosis. Acta Paediatr 85:49–55 (EK IIb)PubMedCrossRef

576.

Svensson J, Johannesen J, Mortensen HB, Nordly S (2009) Improved metabolic outcome in a Danish diabetic paediatric population aged 0–18 yr: results from a nationwide continuous Registration. Pediatr Diabetes 10:461–467 (EK III)PubMedCrossRef

577.

Svoren BM, Butler D, Levine BS, Anderson BJ, Laffel LM (2003) Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial. Pediatrics 112:914–922 (EK Ib)PubMedCrossRef

578.

Svoren BM, Volkening LK, Butler DA, Moreland EC, Anderson BJ, Laffel LM (2007) Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr 150:279–285 (EK IIa)PubMedPubMedCentralCrossRef

579.

Swift PG (2007) Diabetes education. ISPAD clinical practice consensus guidelines 2006–2007. Pediatr Diabetes 8:103–109 (EK IV)PubMedCrossRef

580.

Swift PG, Skinner TC, de Beaufort CE, Cameron FJ, Aman J, Aanstoot HJ, Castano L, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njolstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE (2010) Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr Diabetes 11:271–278 (EK III)PubMedCrossRef

581.

Taha D, Umpaichitra V, Banerji MA, Castells S (2006) Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance. J Pediatr Endocrinol Metab 19:135–142 (EK IIb)PubMedCrossRef

582.

Takii M, Uchigata Y, Komaki G, Nozaki T, Kawai H, Iwamoto Y, Kubo C (2003) An integrated inpatient therapy for type 1 diabetic females with bulimia nervosa: a 3-year follow-up study. J Psychosom Res 55:349–356 (EK III)PubMedCrossRef

583.

Tansey MJ, Tsalikian E, Beck RW, Mauras N, Buckingham BA, Weinzimer SA, Janz KF, Kollman C, Xing D, Ruedy KJ, Steffes MW, Borland TM, Singh RJ, Tamborlane WV (2006) The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 29:20–25 (EK Ib)PubMedCrossRef

584.

Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP (2000) Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 49:1359–1366 (EK III)PubMedCrossRef

585.

Temple IK, Shield JP (2002) Transient neonatal diabetes, a disorder of imprinting. J Med Genet 39:872–875, EK IV

586.

Thalange N, Deeb L, Iotova V, Kawamura T, Klingensmith G, Philotheou A, Silverstein J, Tumini S, Ocampo Francisco AM, Kinduryte O, Danne T (2015) Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Pediatr Diabetes 16:164–176 (EK Ib)PubMedPubMedCentralCrossRef

587.

Thisted H, Johnsen SP, Rungby J (2006) An update on the longacting insulin analogue glargine. Basic Clin Pharmacol Toxicol 99:1–11 (EK Ia)PubMedCrossRef

588.

Thompson SJ, Auslander WF, White NH (2001) Comparison of single-mother and two-parent families on metabolic control of children with diabetes. Diabetes Care 24:234–238 (EK IIa)PubMedCrossRef

589.

Thomsen C, Storm H, Holst JJ, Hermansen K (2003) Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr 77:605–611 (EK Ib)PubMedCrossRef

590.

Thorpe CT, Fahey LE, Johnson H, Deshpande M, Thorpe JM, Fisher EB (2013) Facilitating healthy coping in patients with diabetes: a systematic review. Diabetes Educ 39:33–52 (EK Ia)PubMedCrossRef

591.

Thurber BW, Carmody D, Tadie EC, Pastore AN, Dickens JT, Wroblewski KE, Naylor RN, Philipson LH, Greeley SA (2015) Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes. Diabetologia 58:1430–1435 (EK III)PubMedPubMedCentralCrossRef

592.

Tiberg I, Katarina SC, Carlsson A, Hallstrom I (2012) Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-based care. Acta Paediatr 101:1069–1073 (EK Ib)PubMedCrossRef

593.

Toeller M. (nach Mann et al (2005) Evidenz-basierte Ernährungsempfehlungen zur Behandlung und Prävention des Diabetes mellitus. Diabetes Stoffwechs 14:75–94 (EK Ia–IV)

594.

Toni S, Reali MF, Barni F, Lenzi L, Festini F (2006) Managing insulin therapy during exercise in type 1 diabetes mellitus. Acta Biomed 77(Suppl 1):34–40 (EK IIa–III)PubMed

595.

Triolo TM, Armstrong TK, McFann K, Yu L, Rewers MJ, Klingensmith GJ, Eisenbarth GS, Barker JM (2011) Additional autoimmune disease found in 33 % of patients at type 1 diabetes onset. Diabetes Care 34:1211–1213 (EK III)PubMedPubMedCentralCrossRef

596.

Tsalikian E, Kollman C, Tamborlane WB, Beck RW, Fiallo-Scharer R, Fox L, Janz KF, Ruedy KJ, Wilson D, Xing D, Weinzimer SA (2006) Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 29:2200–2204 (EK Ib)PubMedCrossRef

597.

Tsiouli E, Alexopoulos EC, Stefanaki C, Darviri C, Chrousos GP (2013) Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes: Systematic review. Can Fam Physician 59:143–149 (EK Ib)PubMedPubMedCentral

598.

Tubiana-Rufi N, Coutant R, Bloch J, Munz-Licha G, Delcroix C, Montaud-Raguideau N, Ducrocq R, Limal JM, Czernichow P (2004) Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study. Horm Res 62:265–271 (EK Ib)PubMed

599.

Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350 (EK Ib)PubMedCrossRef

600.

Tupola S, Komulainen J, Jaaskelainen J, Sipila I (2001) Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus. Diabet Med 18:654–658 (EK Ib)PubMedCrossRef

601.

UK Prospective Diabetes Study (UKPDS) Group (1998a) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854–865 (EK Ib)CrossRef

602.

UK Prospective Diabetes Study (UKPDS) Group (1998b) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837–853 (EK Ib)CrossRef

603.

UK Prospective Diabetes Study (UKPDS) Group (1998c) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713 (EK Ib)CrossRef

604.

Vaarala O, Klemetti P, Juhela S, Simell O, Hyoty H, Ilonen J (2002) Effect of coincident enterovirus infection and cows’ milk exposure on immunisation to insulin in early infancy. Diabetologia 45:531–534 (EK Ib)PubMedCrossRef

605.

Valenzuela JM, Patino AM, McCullough J, Ring C, Sanchez J, Eidson M, Nemery R, Delamater AM (2006) Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes. J Pediatr Psychol 31:650–660 (EK IIb)PubMedCrossRef

606.

van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG (2008) Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 7:515–519 (EK III)PubMedCrossRef

607.

Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44:312–319 (EK Ib)PubMedCrossRef

608.

Viklund G, Ortqvist E, Wikblad K (2007) Assessment of an empowerment education programme. A randomized study in teenagers with diabetes. Diabet Med 24:550–556 (EK Ib)PubMedCrossRef

609.

Viner RM, Christie D, Taylor V, Hey S (2003) Motivational/solutionfocused intervention improves HbA1c in adolescents with Type 1 diabetes: a pilot study. Diabet Med 20:739–742 (EK III)PubMedCrossRef

610.

von Sengbusch S, Muller-Godeffroy E, Hager S, Reintjes R, Hiort O, Wagner V (2006) Mobile diabetes education and care: intervention for children and young people with Type 1 diabetes in rural areas of northern Germany. Diabet Med 23:122–127, EK IIb

611.

Wabitsch M, Hertrampf M, Mayer H, Heinze E (2002) Glucosetoleranz und Insulinresistenz bei Kindern und Jugendlichen mit Adipositas. Diabetes Stoffwechs 34(Suppl 10): (EK III)

612.

Wagner VM, Grabert M, Holl RW (2005) Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial—a large-scale multicentre study. Eur J Pediatr 164:73–79 (IIb–III)PubMedCrossRef

613.

Wagner VM, Kremke B, Hiort O, Flanagan SE, Pearson ER (2009) Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2—initial and long-term response to sulfonylurea therapy. Eur J Pediatr 168:359–361PubMedCrossRef

614.

Waldron S, Rurik I, Madacsy L, Donnasson-Eudes S, Rosu M, Skovlund SE, Pankowska E, Allgrove J (2012) Good practice recommendations on paediatric training programmes for health care professionals in the EU. Pediatr Diabetes 13(Suppl 16):29–38 (EK IV)PubMedCrossRef

615.

Wambach JA, Marshall BA, Koster JC, White NH, Nichols CG (2010) Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to a KCNJ11 mutation. Pediatr Diabetes 11:286–288PubMedCrossRef

616.

Wang YC, Stewart SM, Mackenzie M, Nakonezny PA, Edwards D, White PC (2010) A randomized controlled trial comparing motivational interviewing in education to structured diabetes education in teens with type 1 diabetes. Diabetes Care 33:1741–1743 (EK Ib)PubMedPubMedCentralCrossRef

617.

Warncke K, Frohlich-Reiterer EE, Thon A, Hofer SE, Wiemann D, Holl RW (2010) Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28 671 patients from the German/Austrian DPV-Wiss database. Diabetes Care 33:2010–2012 (EK III)PubMedPubMedCentralCrossRef

618.

Watts GF, Gregory L, Naoumova R, Kubal C, Shaw KM (1988) Nutrient intake in insulin-dependent diabetic patients with incipient nephropathy. Eur J Clin Nutr 42:697–702 (EK III)PubMed

619.

Weinzimer SA, Swan KL, Sikes KA, Ahern JH (2006) Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes. Pediatr Diabetes 7(Suppl 4):15–19 (EK Ia–III)PubMedCrossRef

620.

Weissberg-Benchell J, Glasgow AM, Tynan WD, Wirtz P, Turek J, Ward J (1995) Adolescent diabetes management and mismanagement. Diabetes Care 18:77–82 (EK III)PubMedCrossRef

621.

Weitzel D, Obermann B, Rogge R (1997) Tagesklinische Ersteinstellung des kindlichen und jugendlichen IDDM. Diabet Stoffw 6:110 (EK IV)

622.

Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, Shahinfar S (2002) A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol 42:870–880 (EK Ib)PubMedCrossRef

623.

White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV (2001) Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 139:804–812PubMedCrossRef

624.

White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 126:1707–1715 (EK Ib)PubMedCrossRef

625.

Whittemore R, Jaser S, Chao A, Jang M, Grey M (2012) Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ 38:562–579 (EK Ib)PubMedPubMedCentralCrossRef

626.

Wiebe DJ, Berg CA, Korbel C, Palmer DL, Beveridge RM, Upchurch R, Lindsay R, Swinyard MT, Donaldson DL (2005) Children’s appraisals of maternal involvement in coping with diabetes: enhancing our understanding of adherence, metabolic control, and quality of life across adolescence. J Pediatr Psychol 30:167–178 (EK III)PubMedCrossRef

627.

Wisting L, Froisland DH, Skrivarhaug T, Dahl-Jorgensen K, Ro O (2013) Disturbed eating behavior and omission of insulin in adolescents receiving intensified insulin treatment: a nationwide population-based study. Diabetes Care 36:3382–3387 (EK III)PubMedPubMedCentralCrossRef

628.

Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WR, Rosenbloom A, Sperling MA, Hanas R (2007) Diabetic ketoacidosis. Pediatr Diabetes 8:28–43 (EK IV)PubMedCrossRef

629.

Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, Lee WW, Mungai LN, Rosenbloom AL, Sperling MA, Hanas R (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 15(Suppl 20):154–179 (EK IV)PubMedCrossRef

630.

Wolfsdorf JI, Glaser N, Agus M et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 19(Suppl 27):155–177. https://doi.org/10.1111/pedi.12701 (No abstract available)CrossRefPubMed

631.

Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LM (2006) Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 29:2355–2360 (EK IIb–III)PubMedCrossRef

632.

World Health Organinsation (WHO): (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Report of a Joint FAO/WHO Expert Consultation. Technical Report Series, Bd. 916. WHO, Geneva (EK IV)

633.

Wühl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) Distribution of 24‑h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007 (EK IIb)PubMedCrossRef

634.

Wysocki T, Greco P, Harris MA, Bubb J, White NH (2001) Behavior therapy for families of adolescents with diabetes: maintenance of treatment effects. Diabetes Care 24:441–446 (EK IIa)PubMedCrossRef

635.

Wysocki T, Harris MA, Buckloh LM, Mertlich D, Lochrie AS, Mauras N, White NH (2007) Randomized trial of behavioral family systems therapy for diabetes: maintenance of effects on diabetes outcomes in adolescents. Diabetes Care 30:555–360 (EK Ib)PubMedCrossRef

636.

Wysocki T, Harris MA, Buckloh LM, Mertlich D, Lochrie AS, Taylor A, Sadler M, White NH (2008) Randomized, controlled trial of Behavioral Family Systems Therapy for Diabetes: maintenance and generalization of effects on parent-adolescent communication. Behav Ther 39:33–46, EK Ib

637.

Wysocki T, Harris MA, Greco P, Bubb J, Danda CE, Harvey LM, McDonell K, Taylor A, White NH (2000) Randomized, controlled trial of behavior therapy for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol 25:23–33 (EK Ib)PubMedCrossRef

638.

Wysocki T, Lochrie A, Antal H, Buckloh LM (2011) Youth and parent knowledge and communication about major complications of type 1 diabetes: associations with diabetes outcomes. Diabetes Care 34:1701–1705 (EK Ib)PubMedPubMedCentralCrossRef

639.

Wysocki T, Lochrie A, Antal H, Buckloh LM (2011) Youth and parent knowledge and communication about major complications of type 1 diabetes: associations with diabetes outcomes. Diabetes Care 34:1701–1705 (EK III)PubMedPubMedCentralCrossRef

640.

Wysocki T, Taylor A, Hough BS, Linscheid TR, Yeates KO, Naglieri JA (1997) Deviation from developmentally appropriate self-care autonomy. Association with diabetes outcomes. Diabetes Care 19:121–125 (EK IIb)

641.

Yokota Y, Kikuchi N, Matsuura N (2004) Screening for diabetes by urine glucose testing at school in Japan. Pediatr Diabetes 5:212–218 (EK III)PubMedCrossRef

642.

Young V, Eiser C, Johnson B, Brierley S, Epton T, Elliott J, Heller S (2013) Eating problems in adolescents with Type 1 diabetes: a systematic review with meta-analysis. Diabet Med 30:189–198 (EK Ia)PubMedCrossRef

643.

Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Barrett T, Maahs D (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Type 2 diabetes in the child and adolescent. Pediatr Diabetes 15:26–46 (EK IV)PubMedCrossRef

644.

Zenlea IS, Mednick L, Rein J, Quinn M, Wolfsdorf J, Rhodes ET (2014) Routine behavioral and mental health screening in young children with type 1 diabetes mellitus. Pediatr Diabetes 15:384–388 (EK III)PubMedCrossRef

645.

Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473–2479PubMedPubMedCentralCrossRef

646.

Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetesassociated autoantibodies. JAMA 290:1721–1728 (EK III)PubMedCrossRef

647.

Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R (2011) Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 12:11–17 (EK III)PubMedCrossRef

648.

Ziegler R, Neu A (2018) Diabetes in Childhood and Adolescence. Dtsch Arztebl Int 115(9):146–156. https://doi.org/10.3238/arztebl.2018.0146CrossRefPubMedPubMedCentral

649.

Zung A, Glaser B, Nimri R, Zadik Z (2004) Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504–5507, EK III

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter

Auszug

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Diabetes und Gastroenterologie – Update 2021

DIfE – Deutscher Diabetes-Risiko-Test®

Gewichts(un)abhängige Effekte von Tirzepatid

Screening und Epidemiologie des Diabetes

Für Sie kommentiert: neue Studien zu Hypertonie und Diabetes

Diabetes mellitus im Alter

Praxisempfehlungen der Deutschen Diabetes Gesellschaft